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Abstract and Keywords

Cyclopropane 1,1-diesters have been investigated as a source of donor-acceptor
cyclopropanes, providing an understanding of the mechanism of reaction between these
cyclopropanes and nitrosoarenes, as well as azo dicarboxylates. Cross-over experiments have been
utilized to provide key pieces of experimental evidence that help generate a theoretical model of
the reactions. By understanding these reactions with precision, the avenue to expand the reaction
scope and develop other useful reactions is opened up. This allows the chemistry to be better
utilized, providing easier access to important molecules when needed, and contributes to
advancing the field of synthetic organic chemistry.
In addition, cyclobutane 1,1-diesters were also investigated as a source of donor-acceptor
cyclobutanes. Specifically, their use in cycloaddition reactions has been developed to include the
reaction of cyclobutanes with cis-diazenes, providing access to hexahydropyridazines. These
compounds are synthesized in an efficient manner and are known to contain biologically active
properties.
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Chapter 1 - General Introduction

The use of cyclopropanes and cyclobutanes in synthetic organic chemistry has received a
considerable amount of attention over the years, with multiple applications being continually
developed. This chapter serves as an introduction to the chemistry of donor-acceptor (DA)
cyclopropanes and cyclobutanes, and their utilization in the synthesis of heterocyclic ring systems.
The focus of the reactions is on the use of 1,1-cyclopropanediesters as a source of DA
cyclopropanes. The work presented in this thesis was done entirely by me, and the information
acquired will be published in peer-reviewed journals in the near future.
Chapter two investigated the reaction of DA cyclopropanes with nitrosoarenes with the use
of a cross-over experiment to acquire key experimental data that were used to validate a potential
reaction mechanism. The chemistry of DA cyclopropanes with nitrones is well known, but similar
products were produced when the nitrone was switched with a nitroso functional group, so a
complete mechanism would be valuable for not only understanding this reaction, but in the
development of new reactions to come when utilizing DA cyclopropanes.
Chapter three investigated the reaction of DA cyclopropanes with both cis and trans azo
dicarboxylates. The chemistry behind the unusual ring opening reaction of DA cyclopropanes with
specifically cis-diazenes was a key component of this chapter. The use of cross-over experiments
was used to gain a deeper understanding into these reactions and resulted in a new pattern of
reactivity which showed similarities to the chemistry presented in chapter two as well.
Chapter four investigated the use of DA cyclobutanes in a new cycloaddition reaction with
cis azo dicarboxylates. It was shown that DA cyclobutanes are able to react with cis-diazenes and
form hexahydropyridazines ring systems which are a rare type of heterocycle, which have only a
limited number of synthetic procedures available.
The chemistry learned throughout these chapters has shown new procedures to construct
heterocyclic compounds from DA cyclopropanes and cyclobutanes, and answer mechanistically
related questions into how these compounds form. These experimental observations have shown
repeating patterns of reactivity that potentially could be adjusted to include the incorporation of
new elements, and hopefully help in the discovery or design of new reactions.
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1.1 Introduction
Cyclopropanes and cyclobutanes have been shown to play an important and useful role in
synthetic organic chemistry with an array of various reaction partners.1 Comparison of the
properties of carbocycles show cyclopropane and cyclobutane to have a higher ring strain energy
due to the distortion of the bond angles away from the ideal 109° angle of the tetrahedron. Figure
1.1 describes the higher ring strain energy of cyclic compounds when the carbon-carbon bond
angles in cyclopropane (1) and cyclobutane (2) are not able to adopt an ideal conformation such
as the lower energy chair form of cyclohexane (4).2 When smaller carbocycles are prepared, their
inherent ring strain functions as a built-in energy source which can be used as a driving force to
produce compounds with various uses in chemical synthesis. The unique properties of
cyclopropanes allow for a very useful activation of sp3 C-C bonds within the cycle, which has
contributed to an array of different reaction types. These properties are also useful in biological
settings with many cyclopropane ring-opening reactions occurring in nature.

Figure 1.1 Strain energies of small carbocycles
Cyclopropanes are found in natural products and biological settings, including lipids,
pheromones, terpenes, and steroids.3 Examples include the anti-HIV drug Nevirapine (5), and the
potent antibiotics Ciprofloxacin (6) and Vigamox (7) as seen in Figure 1.2. Vigamox was ranked
in the top 200 brand-name drugs by U.S. retail dollars in 2010 with a profit that year of $0.25
billion.4
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Figure 1.2 Examples of biologically active compounds containing a cyclopropane ring
Cyclopropanes have had many uses in synthetic chemistry, such as in total synthesis, and
in the preparation of many useful compounds. In order to make use of the cyclopropane ring and
control which bonds will break to undergo reaction, activating groups are strategically used. The
cyclopropane ring is reactive due to its high ring strain, but activating groups are commonly present
on the ring to selectively increase, and control reactivity. The effects of activating groups can also
be enhanced or activated using thermal or catalytic conditions.
1.1.1 Donor-Acceptor (DA) Cyclopropanes
Increased reactivity can be achieved when donor and acceptor groups are arranged in a
vicinal relationship on the carbocycle to activate the bond between the two groups and allow for
different reaction types.5 Common examples of electron donating groups (EDG) include: alkoxy,
amino, aryl, vinyl, and other groups that can stabilize carbocations. Examples of electron
withdrawing groups (EWG) commonly include: esters, carbonyls, and other groups that can
stabilize carbanions.6
Activation of donor-acceptor (DA) cyclopropanes (8) and cyclobutanes with Lewis acids
allow formation of 1,3-dipole (9) and 1,4-dipole intermediates, respectively. Scheme 1.1 shows
how DA cyclopropanes are able to react with various electrophiles, nucleophiles, or dipolarophiles.
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Scheme 1.1 General reactions of DA cyclopropanes
DA cyclopropanes have been extensively studied over the last 50 years and serve as a
synthetically useful 1,3 carbon dipolarophile. This allows for multiple applications such as serving
as starting materials for the synthesis of highly substituted 5- and 6-membered carbocycles and
heterocycles via annulation (cycloaddition) reactions.
1.1.2 Cycloadditions of DA Cyclopropanes
Cycloaddition chemistry has the ability to produce a wide range of molecular architecture
often with high levels of control and efficiency.7 Cycloadditions have also proven to be an effective
method for the construction of heterocyclic compounds. The ability to efficiently access different
heterocyclic motifs has great importance because of the interesting biological activities that are
often associated with the systems when found in living organisms. Active heterocycles have shown
considerable

biological

actions,

such

as

antifungal,

anti-inflammatory,

antibacterial,

anticonvulsant, antiallergic, herbicidal, anticancer activity.8 A main focus of this thesis is on
cycloadditions of DA cyclopropanes with different dipolarophiles, and understanding their
mechanism of action in the creation of heterocyclic compounds.
Cycloadditions belong to a broader class of reactions known as pericyclic reactions.
Pericyclic reactions are often characterized by a simultaneous event of bond breaking and bond
creating in the reaction process. This attribute often provides a way of controlling the
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stereochemistry for a specific reaction. In some cases, the stereochemistry of the starting material
can control the stereochemical outcome of the product. This type of prediction is made more
accurately when a complete understanding of the reaction mechanism and transition states are
known.
Typical cycloadditions often occur through tightly held or compact transition states which
is governed my maximum orbital overlap between reaction partners.9 These so-called “closed”
transition states are powerful tools in the asymmetric synthesis field for analyzing enantioselective and diastereo-selective reactions. Acquiring accurate models of transition states is
therefore of upmost importance in the understanding of stereo-selective reactions. In addition to
understanding transition states, it may also be of equal importance to understand the overall
mechanism of a reaction.
DA cyclopropanes, such as 1,1-cyclopropane diesters react in a similar way to alkenes
substituted with an electron withdrawing group (EWG), such as α,β-unsaturated carbonyl
systems.10 The difference is the additional carbon in the cyclopropane ring, which makes the
reaction a one carbon homologation as seen in the [3+2], and homo [3+2] cycloaddition (Scheme
1.2).

Scheme 1.2 Cycloaddition of nitrones with α,β-unsaturated systems and cyclopropanes
1.1.3 Cycloadditions of DA Cyclopropanes with Nitrones
Nitrones (13) have been shown to react with 1,1-cyclopropane diesters (18) in the presence
of Yb(OTf)3 to yield tetrahydro-1,2-oxazines (19) with a high degree of regio- and stereo-control,
as seen in scheme 1.3.11
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Scheme 1.3 Homo [3+2] cycloaddition of nitrones with DA cyclopropanes
Single-crystal X-Ray analysis has shown that the observed product always forms a single
diastereomer in which the substituents at the C3 and C6 position are always in a cis relationship.
This type of transformation is an example of a dipolar homo [3+2] cycloaddition, but is also
considered a 1,3-dipolar cycloaddition, and was first reported by the Kerr group in 2003.
Mechanistic studies have been carried out with quantum chemical DFT calculations and indicate
that two very similar, but distinct, reaction pathways may account for the transformation, and can
be seen in Scheme 1.4.12 One pathway is an asynchronous concerted mechanism that involves an
approximate half-chair-like transition state where the oxygen of the nitrone leads the attack on the
cyclopropane ring (I). The second pathway is a stepwise mechanism which involves a zwitterionic
imminium intermediate, with the oxygen of the nitrone again leading the attack on the
cyclopropane ring (II). Understanding this transformation in detail has helped discover another
transformation, where DA cyclopropanes are capable of reacting with nitrosoarenes.
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Scheme 1.4 Mechanism of cycloaddition of DA cyclopropanes with nitrones
In 2004 the Kerr group showed that this reaction could be carried out using a threecomponent coupling strategy between an aldehyde (21) and a hydroxylamine (20) as seen in
Scheme 1.5. In this strategy, the nitrone (13) is formed in situ, which is useful when dealing with
nitrones that are difficult to prepare or are unstable due to oligomerization under the required Lewis
acidic conditions.13

Scheme 1.5 Three-component homo [3+2] cycloaddition
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In order to address the issue as to whether this reaction mechanism is going through a
concerted or step-wise pathway, extensive studies were performed using enantio-pure starting
materials. Therefore the reaction of enantiomerically enriched 3-methyl-2-phenylcyclopropane1,1-dicarboxylates with nitrones was performed by Dr. Michael Kerr in 200714, as shown in
scheme 1.6.

Scheme 1.6 Mechanism studies on cycloadditions of DA cyclopropanes with nitrones
A key piece of information discovered in this study is the inversion of stereochemistry at
C2 for both cis and trans diastereomers of the starting material. The results provided experimental
evidence that supports the idea of a step-wise pathway and not a concerted pathway. In the stepwise pathway, there is an inversion of stereochemistry when the oxygen from the nitrone acts as a
nucleophile and opens the cyclopropane ring.
Experimental evidence that also helps support the mechanism proposed by Dr. Michael
Kerr was provided when optically active cyclopropanes were reacted with nitrones in the presence
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of a catalytic amount of Ni(ClO4)2 without a chiral ligand to give the tetrahydro-1,2-oxazine in a
high yield with the same level of enantiomeric purity as that of the starting material.15
This work by Tang et al shows how understanding the proposed mechanism of a reaction
can lead to other discoveries, in this case, applications for kinetic resolution was developed. This
was made possible because of the diligent mechanistic studies performed by Dr. Michael Kerr to
understand the reaction with a high level of understanding.
1.1.4 Tetrahydro-1,2-Oxazines
The tetrahydro-1,2-oxazine motif is rarely found in nature, appearing in only a small
number of natural products. Examples of these natural products include FR900482 (27) and
FR66979 (28) as seen in Figure 1.3, which exhibit antitumor and antibiotic properties.16 Both of
these natural products are structurally similar to the mitomycins, including mitomycin C, which
has been in widespread clinical use for more than 20 years. The biological activities of FR900482
and FR66979 are also similar to the mitomycins, which are both reductively activated in vivo and
covalently cross-link DNA in a fashion analogous to the mitomycins. The difference in structures
that ultimately causes a different mechanism of bio-reductive activation between the mitomycins
and FR900482, cause FR900482 to not exhibit oxidative strand scission of DNA and to not
produce a superoxide radical anion during activation. The FR900482 class of compounds
represents a compelling clinical replacement for mitomycin C, given its greatly reduced host
toxicity and superior DNA interstrand cross-linking efficacy.

Figure 1.3 Tetrahydro-1,2-oxazine motif in natural and synthetic compounds
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FK317 (29) and FK973 (30) are synthetic analogs of the natural products FR900482 and
FR66979, and also contain the tetrahydro-1,2-oxazine system. The antitumor activity of FK317
was found to be equivalent to, or stronger than cisplatin, mitomycin C, and Taxol. Because of
compounds such as FR900482 and FR66979 which contain the tetrahydro-1,2-oxazine system and
show interesting biological features, new synthetic routes to the tetrahydro-1,2-oxazine core are
useful because of the limited ways in which these systems can be created. These limitations have
made the tetrahydro-1,2-oxazine ring difficult to synthesize in the past, so having the ability to
form the system in a controlled manner is definitely beneficial to the synthetic community. This
project looks at how cycloaddition chemistry can be utilized as an effective method for
heterocyclic ring construction, and how understanding the process mechanistically may lead to the
discovery of other reaction types. It is already know that DA cyclopropanes react with nitrones to
form the tetrahydro-1,2-oxazine ring, and a goal of this project is to discover other partners that
are compatible with DA cyclopropanes to form these systems as well as other interesting
heterocycles.
The post modification of tetrahydro-1,2-oxazines has been examined by Dr. Michael Kerr
and has led to some interesting and important uses for the ring system. Selective N-O cleavage of
the tetrahydro-1,2-oxazine ring has been utilized in the synthesis of amino alcohols. The amino
alcohols have then been used to construct pyrrolidines which has applications in the total synthesis
of Nakadomarin A for example.17 Pyrrole synthesis has also emerged as a tool made possible from
post modification of the ring system.18 These useful applications showcase how important these
molecules are, and how important it is to obtain these compounds in an efficient and controllable
manner.
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Chapter 2 - Cycloadditions of Donor-Acceptor Cyclopropanes with Nitrosoarenes
2.1 Introduction
Nitrosoarenes have been coupled with DA cyclopropanes in the synthesis of various
heterocyclic ring systems.19 Although reactions of nitrosoarenes and DA cyclopropanes have been
reported, their potential has still yet to be reached. The discovery of new reactions utilizing the
nitroso functional group is still ongoing and demonstrates the versatility in the construction of
heterocyclic systems. The nitrogen-oxygen single bond that forms when nitrosoarenes are used in
ring construction, has been shown to be a site of functionalization for the production of important
molecules such as amino alcohols.20
2.1.1 Cycloadditions of DA Cyclopropanes with Nitrosoarenes
Previous research in the Studer group21 has shown DA cyclopropanes to be a compatible
reaction partner with nitrosoarenes, which undergo a [3+2] cycloaddition forming isoxazolidines
when catalyzed with MgBr2 as seen in scheme 2.1. The successful use of DA cyclopropanes with
nitrosoarenes in cycloaddition reactions encouraged the Pagenkopf group to determine if these
reaction partners were able to undergo other transformations.

Scheme 2.1 [3+2] Cycloaddition of DA cyclopropanes with nitrosoarenes
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Figure 2.1 Catalytic cycle of [3+2] cycloaddition of DA cyclopropanes with nitrosoarenes
The mechanism (Figure 2.1) shows a bromide ion attacking and opening the cyclopropane
ring, which drew my attention because of the Pagenkopf group’s interest in Yb(OTf)3 catalyzed
DA cyclopropane cycloaddition chemistry. Under Yb(OTf)3 catalytic conditions, only the triflate
ion would be present as a counter-ion and would presumably be less nucleophilic towards the
cyclopropane, allowing the nitrosoarene a chance to act as the nucleophile and perhaps open the
cyclopropane ring in a [3+2] annulation to yield an isooxazolidinine. The initial hope was in
opening of the DA cyclopropane in a manner that would yield the opposite regio-isomer as the
Studer group. Instead of observing an isooxazolidinine, a tetrahydro-1,2-oxazine motif was
formed.
2.2 Results and Discussion
Interestingly, it was discovered that when nitrosoarenes were allowed to react with DA
cyclopropanes, the tetrahydro-1,2-oxazine motif was formed when catalyzed with Yb(OTf)3 under
refluxing conditions. The observed cis stereochemical outcome of the tetrahydro-1,2-oxazine ring
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is consistent with Kerr’s reaction of DA cyclopropanes with nitrones. A nitrone intermediate may
account for the formation of the tetrahydro-1,2-oxazine system. This assumption was backed up
by experimental evidence when considering the yield of the reaction. When both starting materials
were used in a 1:1 ratio of equivalents, a yield of 44% was observed (Scheme 2.2). When using a
2:1 ratio of cyclopropane to nitrosoarene, a yield of 87% was observed. This observation shows
how two equivalents of the cyclopropane may be combining to form a nitrone in situ, which then
reacts with the nitrosoarene. Understanding the mechanics of this unprecedented reaction may lead
to the discovery of other reaction types and reaction partners for DA cyclopropanes.

Scheme 2.2 Reaction of DA cyclopropane with nitrosoarene
The physical properties of the tetrahydro-1,2-oxazine produced by this method are an exact
match to the tetrahydro-1,2-oxazine produced from Kerr’s methodology. The 1H NMR of
compound 35a prepared from DA cyclopropane 34a and nitrosobenzene 32a is shown in Figure
2.2.

Figure 2.2 1H NMR of tetrahydro-1,2-oxazine 35a
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The NMR of the product from scheme 2.2 was compared to the identical compound
synthesized using Kerr’s three-component coupling strategy and is shown in Scheme 2.3 and
Figure 2.3.

Scheme 2.3 Three component synthesis of tetrahydro-1,2-oxazine

Figure 2.3 1H NMR of tetrahydro-1,2-oxazine 35a prepared from Kerr’s method
The matching NMR data provided experimental evidence that both methods lead to the
same compound and, therefore, access to tetrahydro-1,2-oxazine is possible when reacting 1,1cyclopropane diesters with nitrosoarene compounds.
To find reaction conditions that produce the highest yields and come to a better
understanding of this reaction, an optimization experiment was carried out (Table 2.1). The
reaction of DA cyclopropanes with nitrosoarenes was performed under different conditions until
the production of tetrahydro-1,2-oxaizine was achieved in an efficient and reproducible manner.
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Table 2.1 Optimization of Yb(OTf)3 catalyzed reaction of DA cyclopropanes with nitrosoarene

Entrya

a

1

Cyclopropane
(Equivalents)
1

Nitrosoarene
(Equivalents)
2

Time
(Hours)
20

Yb(OTf)3
(mol %)
10

Yield
(%)b
42

2

1

1

20

10

44

3

2

1

18

10

87

4

4

1

16

10

76

5

2

1

15

5

72

6

2

1

9

20

80

Typical reaction conditions: Cyclopropane and nitrosoarene were added to a solution of

Yb(OTf)3 in 1,2-DCE (3 mL) at room temperature. Reactions were monitored by thin layer
chromatography (TLC) until cyclopropane was consumed. b Isolated yield.

A cross-over experiment, which is a method used to study the mechanism of a chemical
reaction, was used to address this reaction and the experimental evidence gained would help
develop a rational reaction mechanism. A mechanism that would account for this overall
transformation is shown in Scheme 2.4, and demonstrates how the nitrosoarene starts by attacking
the first equivalent of cyclopropane, then forming a nitrone in situ. The nitrone would then react
with the second equivalent of cyclopropane, in a known homo [3+2] cycloaddition, shown in a
step-wise sequence.
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Scheme 2.4 Proposed mechanism for the reaction of DA cyclopropanes with nitrosoarenes
To investigate the proposed reaction mechanism, a cross-over experiment was designed to
provide key mechanistic details. The theoretical mechanism can be analyzed by using two different
cyclopropanes as the starting materials in a cross-over experiment with nitrosobenzene.
2.2.1 Synthesis of DA cyclopropanes
Cyclopropanes were prepared using a two-step procedure utilizing a Knoevenagel
condensation followed by a Corey-Chaykovsky reaction (Table 2.2). Two different cyclopropanes
were required for the cross-over experiment and additional cyclopropanes were also prepared to
explore the reaction scope for compatibility with various nitrosoarenes.
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Table 2.2 Synthesis of DA cyclopropanes

Entrya

Cyclopropane

Product

Yield (% over 2
steps)b

a

1

Ar = C6H5, R = Me

34a

76

2

Ar = 4-MeC6H4, R = Me

34b

87

3

Ar = C6H5, R = Et

34c

82

4

Ar = 4-MeC6H4, R = Et

34d

83

5

Ar = 2-thienyl, R = Me

34e

70

Typical reaction conditions: L-Proline (1.88 mmol) was added to a solution of aldehyde

(18.8 mmol) in DMSO (6 mL) followed by dialkyl malonate (37.6 mmol) and stirred for 24
h at room temperature. NaH (1.7 mmol) was added to trimethylsulfoxonium iodide (1.7
mmol) in DMF (3 mL) and stirred for 1 h at room temperature before adding the Knoevenagel
product (1.4 mmol). Reactions were monitored by TLC until cyclopropane was consumed. b
Isolated yield.

2.2.2 Cross-Over Experiment #1
Using starting material that consisted of two different DA cyclopropanes (34a, 34d) would,
in theory, generate two different nitrone intermediates (38, 43) as seen in Scheme 2.5. Nitrone
intermediate 38 would react with cyclopropane 34a and cyclopropane 34d giving rise to products
35a and 35c. The other nitrone intermediate (43) would react again with cyclopropane 34a and
cyclopropane 34d, giving rise to products 35b and 35d. Identification of all four products in the
reaction mixture would confirm that a reaction is taking place in which there is cross-over between
the two different cyclopropanes and the two different nitrone intermediates.
The four expected products were synthesized individually from a three component
coupling, homo [3+2] dipolar cycloaddition. Once each tetrahydro-1,2-oxazine product was
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synthesized, they were used as standards and compared against the reaction mixture of the crossover experiment. The three component coupling reaction was performed by making a nitrone in
situ from the respective aldehyde and hydroxylamine as seen in Table 2.3.
Table 2.3 Synthesis of tetrahydro-1,2-oxazine standards

Entrya

a

Aldehyde

Cyclopropane

Product

Yield (%)b

1

Ar1 = C6H5

Ar2 = C6H5, R= Me

35a

64

2

Ar1 = 4-MeC6H4

Ar2 = C6H5, R= Me

35b

81

3

Ar1 = C6H5

Ar2 = 4-MeC6H4, R= Et

35c

77

4

Ar1 = 4-MeC6H4

Ar2 = 4-MeC6H4, R= Et

35d

63

Typical reaction conditions: To a solution of hydroxylamine (0.46 mmol) and

aldehyde (0.50 mmol) in toluene (2 mL) at room temperature, were added Yb(OTf)3
and 4Å molecular sieves. Reactions were monitored by TLC. b Isolated yield.

After synthesis and characterization, the standards with their respective Rf values were
spotted against the reaction mixture of the cross-over experiment and developed in Hexanes:Ethyl
Acetate (3:1) on a TLC plate. All four standards in the reaction mixture were identified. All four
tetrahydro-1,2-oxazines (35a - 35d) were isolated from the reaction mixture of cross-over
experiment #1 to provide isolated yields as seen in Scheme 2.5. All four products in the reaction
mixture (from cross-over experiment #1) was verified with NMR and GC-MS data, which were
analyzed by comparison to the individual standards produced from Table 2.3
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Scheme 2.5 Cross-over experiment for the reaction of DA cyclopropanes with nitrosoarenes
2.2.3 Reaction Scope
After gaining a better understanding and optimizing the reaction of DA cyclopropanes with
nitrosoarenes, the optimal conditions were applied to other nitrosoarenes to investigate and expand
the reactions scope, as seen in Table 2.4.
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Table 2.4 Reaction scope with different nitrosoarenes

Entrya

a

Nitrosoarene

Product

Yield (%)b

1

Ar = 3-BrC6H4

44a

73

2

Ar = 4-BrC6H4

44b

75

3

Ar = 3-CO2EtC6H4

44c

80

4

Ar = 4-CO2EtC6H4

44d

78

5

Ar = 3,4-Cl2C6H3

44e

91

6

Ar = 3-C(O)MeC6H4

44f

68

7

Ar = N-Boc-5-Indole

44g

55

Typical reaction conditions: To a solution of Yb(OTf)3 in 1,2-DCE (3 mL) at room

temperature, was added cyclopropane (0.43 mmol) and nitrosoarene (0.22 mmol). Reactions
were monitored by TLC until cyclopropane was consumed. b Isolated yield.
After expansion of the reaction scope to include different nitrosoarenes, additional DA
cyclopropanes were explored. Table 2.5 shows different DA cyclopropanes that are compatible
with the reaction conditions in forming tetrahydro-1,2-oxazines.
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Table 2.5 Reaction scope with different DA cyclopropanes

Entrya

a

Cyclopropane

Product

Yield (%)b

1

Ar = C6H5, R = Me

35a

87

2

Ar = C6H5, R = Et

35e

62

3

Ar = 4-MeC6H4, R = Me

35f

46

4

Ar = 4-MeC6H4, R = Et

35d

70

5

Ar = 2-thienyl, R = Me

35g

69

Typical reaction conditions: To a solution of Yb(OTf)3 in 1,2-DCE (3 mL)

at room temperature, was added cyclopropane (0.43 mmol) and nitrosoarene
(0.22 mmol). Reactions were monitored by TLC until cyclopropane was
consumed. b Isolated yield.
A new method of synthesizing tetrahydro-1,2-oxazines from DA cyclopropanes and
nitrosoarenes under Yb(OTf)3 catalysis has been developed. A mechanism that accounts for this
overall transformation has been presented and experimental data obtained from a cross-over
experiment provided supporting evidence. The reaction scope was investigated and it was found
that the reaction conditions were compatible with different nitrosoarenes and DA cyclopropanes.
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2.3 Experimental
All reactions were performed in an atmosphere of dry argon unless otherwise noted. Flasks
were oven-dried at approximately 110 °C overnight and cooled in a desiccator prior to use.
Solvents and reagents were purified according to standard procedures. Dichloromethane was
purified by passing the solvent through a column of activated alumina. 1,2-Dichloroethane was
dried by stirring with CaH2 for one hour prior to distillation. All other chemicals were of reagent
quality and used as obtained from commercial sources unless otherwise noted. The progress of
reactions was monitored by TLC performed on F254 silica gel plates. The plates were visualized
using UV light (254 nm) or by staining with ceric ammonium molybdate (CAM) or KMnO4.
Column chromatography was performed with Silica Flash P60 60 Å silica gel (purchased from
Silicycle) using flash column chromatography techniques.
1

H and 13C NMR data were obtained on Mercury 400 or Inova 600 MHz spectrometers and

chemical shifts were reported in parts per million (ppm). All spectra were obtained in deuterated
chloroform and referenced to residual chloroform at δ 7.26 ppm for 1H spectra and the center peak
of the triplet at δ 77.0 ppm for 13C spectra. When peak multiplicities are given, abbreviations are
as follows: s, singlet; d, doublet; t, triplet; q, quartet; dd, doublet of doublets; dt, doublet of triplets;
m, multiplet. EI high-resolution mass spectra (HRMS) were recorded on a Finnigan MAT 8200
mass spectrometer at an ionizing voltage of 70 eV.
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2.4 Supporting Information
General Three Component Coupling Procedure
To a solution of hydroxylamine (0.46 mmol, 1.3 equiv) and aldehyde (0.50 mmol, 1.4
equiv), in toluene (2 mL) was added 4Å molecular sieves and Yb(OTf)3 (0.04 mmol, 0.1 equiv)
and stirred for 30 min. Cyclopropane (0.36 mmol, 1.0 equiv) was then added and stirred for 20 h
at rt, then directly loaded onto a packed SiO2 column. Product was purified by flash
chromatography (9:1 hexanes/EtOAc) to afford the corresponding cycloadducts.

Dimethyl 2,3,6-triphenyl-1,2-oxazinane-4,4-dicarboxylate (35a)
The general three component coupling procedure was followed using hydroxylamine (50 mg, 0.46
mmol), aldehyde (0.05 mL, 0.50 mmol), Yb(OTf)3 (22 mg, 0.036 mmol) and cyclopropane 34a
(84 mg, 0.36 mmol) to yield the compound as a yellow oil. The yellow oil was recrystallized with
CH2Cl2/Hexane to give a white solid (100 mg, 64%). Rf 0.40 (3:1 Hexanes:EtOAc); 1H NMR (400
MHz, CDCl3) 7.56 - 7.60 (m, 4 H), 7.47 (app t, J = 7.4 Hz, 2 H), 7.38 - 7.42 (m, 1 H), 7.09 - 7.22
(m, 7 H), 6.81 (app t, J = 7.0 Hz, 1 H), 5.80 (s, 1 H), 5.03 (dd, J = 12.1, 2.3 Hz, 1 H), 3.93 (s, 3 H),
3.48 (s, 3 H), 2.86 (dd, J = 14.5, 12.1 Hz, 1 H), 2.78 (dd, J = 14.5, 2.3 Hz, 1 H); 13C NMR (100
MHz, CDCl3) 170.1, 168.3, 148.5, 139.4, 135.0, 130.4, 128.6, 128.5, 128.3, 128.1, 128.0, 126.5,
121.6, 115.8, 78.8, 65.7, 59.5, 53.5, 52.6, 31.6; HRMS C26H25NO5 Calculated = 431.1733, Found
= 431.1736

24

Dimethyl 2,6-diphenyl-3-(p-tolyl)-1,2-oxazinane-4,4-dicarboxylate (35b)
The general three component coupling procedure was followed using hydroxylamine (60 mg, 0.55
mmol), aldehyde (0.07 mL, 0.60 mmol), Yb(OTf)3 (27 mg, 0.043 mmol) and cyclopropane 34a
(100 mg, 0.43 mmol) to yield the compound as a yellow oil. The yellow oil was recrystallized with
CH2Cl2/Hexane to give a white solid (155 mg, 81%). Rf 0.45 (3:1 Hexanes:EtOAc); 1H NMR (400
MHz, CDCl3) 7.57 (app d, J = 7.4 Hz, 2 H), 7.45 - 7.49 (m, 4 H), 7.38 - 7.42 (m, 1 H), 7.09 - 7.17
(m, 4 H), 7.00 (app d, J = 7.8 Hz, 2 H), 6.79 - 6.83 (m, 1 H), 5.78 (s, 1 H), 5.03 (dd, J = 12.1, 2.3
Hz, 1 H), 3.92 (s, 3 H), 3.51 (s, 3 H), 2.87 (dd, J = 14.5, 12.1 Hz, 1 H), 2.78 (dd, J = 14.5, 2.3 Hz,
1 H), 2.23 (s, 3 H); 13C NMR (100 MHz, CDCl3) 170.1, 168.3, 148.6, 139.5, 137.6, 131.9, 130.3,
121.5, 115.7, 78.8, 77.3, 76.7, 65.4, 59.6, 53.5, 52.7, 31.6, 21.1; HRMS C27H27NO5 Calculated =
445.1889, Found = 445.1882

Diethyl 2,3-diphenyl-6-(p-tolyl)-1,2-oxazinane-4,4-dicarboxylate (35c)
The general three component coupling procedure was followed using hydroxylamine (50 mg, 0.46
mmol), aldehyde (0.05 mL, 0.50 mmol), Yb(OTf)3 (22 mg, 0.036 mmol) and cyclopropane 34d
(100 mg, 0.36 mmol) to yield the compound as a yellow oil. The yellow oil was recrystallized with
CH2Cl2/Hexane to give a white solid (132 mg, 77%). Rf 0.55 (3:1 Hexanes:EtOAc); 1H NMR (400
MHz, CDCl3) 7.57 - 7.59 (m, 2 H), 7.45 (app d, J = 8.2 Hz, 2 H), 7.28 (s, 1 H), 7.08 - 7.17 (m, 7
H), 6.80 (app t, J = 7.0 Hz, 1 H), 5.78 (s, 1 H), 5.00 (dd, J = 12.1, 2.3 Hz, 1 H), 4.38 (q, J = 7.0 Hz,
2 H), 3.87 - 3.94 (dddd, J = 7.0, 7.0, 7.0, 10.5 Hz, 2 H), 2.87 (dd, J = 14.5, 12.1 Hz, 1 H), 2.76 (dd,
J = 14.5, 2.3 Hz, 1 H), 2.41 (s, 3 H), 1.36 (t, J = 7.2 Hz, 3 H), 1.03 (t, J = 7.0 Hz, 3 H); 13C NMR
(100 MHz, CDCl3) 169.6, 168.0, 148.7, 138.1, 136.6, 135.1, 130.6, 129.3, 128.5, 128.0, 127.9,
126.5, 121.4, 115.8, 78.7, 65.7, 62.3, 61.8, 59.4, 31.7, 21.3, 14.2, 13.7; HRMS C29H31NO5
Calculated = 473.2202, Found = 473.2195
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Diethyl 2-phenyl-3,6-di-p-tolyl-1,2-oxazinane-4,4-dicarboxylate (35d)
The general three component coupling procedure was followed using hydroxylamine (50 mg, 0.46
mmol), aldehyde (0.05 mL, 0.50 mmol), Yb(OTf)3 (22 mg, 0.036 mmol) and cyclopropane 34d
(100 mg, 0.36 mmol) to yield the compound as a yellow oil. The yellow oil was recrystallized with
CH2Cl2/Hexane to give a white solid (190 mg, 63%). Rf 0.58 (3:1 Hexanes:EtOAc); 1H NMR (400
MHz, CDCl3) 7.44 - 7.47 (app dd, J = 8.2, 6.6 Hz, 4 H), 7.27 (app d, J = 8.2 Hz, 2 H), 7.08 - 7.16
(m, 4 H), 6.97 (app d, J = 8.2 Hz, 2 H), 6.79 (app tt, J = 7.0, 1.6 Hz, 1 H), 5.75 (s, 1 H), 4.98 (dd,
J = 14.5, 2.3 Hz, 1 H), 4.38 (q, J = 7.0 Hz, 2 H), 3.85 - 3.99 (dddd, J = 7.0, 7.0, 7.0, 10.5 Hz, 2 H),
2.86 (dd, J = 14.5, 12.5 Hz, 1 H), 2.74 (dd, J = 14.5, 2.3 Hz, 1 H), 2.41 (s, 3 H), 2.21 (s, 3 H), 1.35
(t, J = 7.0 Hz, 3 H), 1.06 (t, J = 7.0 Hz, 3 H); 13C NMR (100 MHz, CDCl3) 169.7, 168.0, 148.7,
138.1, 137.5, 136.6, 131.9, 130.5, 129.3, 128.6, 128.5, 126.5, 121.3, 115.7, 78.7, 65.4, 62.2, 61.7,
59.4, 31.7, 21.2, 21.0, 14.2, 13.7; HRMS C30H33NO5 Calculated = 487.2359, Found = 487.2348

General Lewis Acid Catalyzed Cycloaddition Procedure
To a solution of cyclopropane (0.43 mmol, 2.1 equiv) and nitrosoarene (0.20 mmol, 1.0
equiv) in DCE (3 mL) was added Yb(OTf)3 (0.02 mmol, 0.1 equiv) and stirred for 15 min. The
mixture was heated to reflux for 3 h then concentrated after consumption of cyclopropane (as
indicated by TLC) and directly loaded onto a packed SiO2 column. Product was purified by flash
chromatography (9:1 hexanes/EtOAc) to afford the corresponding cycloadducts.

26

Dimethyl 2,3,6-triphenyl-1,2-oxazinane-4,4-dicarboxylate (35a)
The general Lewis acid cycloaddition procedure was followed using cyclopropane 34a (100 mg,
0.43 mmol), nitrosobenzene (21 mg, 0.20 mmol) and Yb(OTf)3 (12 mg, 0.020 mmol) to yield the
compound as a yellow oil, which was recrystallized with CH2Cl2/Hexane to give a white solid (75
mg, 87%). Rf 0.40 (3:1 Hexanes:EtOAc); 1H NMR (400 MHz, CDCl3) 7.56 - 7.60 (m, 4 H), 7.47
(app t, J = 7.4 Hz, 2 H), 7.38 - 7.42 (m, 1 H), 7.09 - 7.22 (m, 7 H), 6.81 (app t, J = 7.0 Hz, 1 H),
5.80 (s, 1 H), 5.03 (dd, J = 12.1, 2.3 Hz, 1 H), 3.93 (s, 3 H), 3.48 (s, 3 H), 2.86 (dd, J = 14.5, 12.1
Hz, 1 H), 2.78 (dd, J = 14.5, 2.3 Hz, 1 H); 13C NMR (100 MHz, CDCl3) 170.1, 168.3, 148.5, 139.4,
135.0, 130.4, 128.6, 128.5, 128.3, 128.1, 128.0, 126.5, 121.6, 115.8, 78.8, 65.7, 59.5, 53.5, 52.6,
31.6; HRMS C26H25NO5 Calculated = 431.1733, Found = 431.1736

Diethyl 2,3,6-triphenyl-1,2-oxazinane-4,4-dicarboxylate (35e)
The general Lewis acid cycloaddition procedure was followed using cyclopropane 34c (50 mg,
0.19 mmol), nitrosobenzene (10 mg, 0.095 mmol) and Yb(OTf)3 (12 mg, 0.019 mmol) to yield the
compound as a yellow oil, which was recrystallized with CH2Cl2/Hexane to give a white solid (28
mg, 62%). Rf 0.46 (3:1 Hexanes:EtOAc); 1H NMR (400 MHz, CDCl3) 7.55 - 7.60 (m, 4 H), 7.47
(app t, J = 7.2 Hz, 2 H), 7.38 - 7.41 (m, 1 H), 7.09 - 7.20 (m, 7 H), 6.81 (app tt, J = 7.0, 1.6 Hz, 1
H), 5.79 (s, 1 H), 5.03 (dd, J = 12.1, 2.3 Hz, 1 H), 4.40 (q, J = 7.0 Hz, 2 H), 3.83 - 3.99 (dddd, J =
7.0, 7.0, 7.0, 10.5 Hz, 2 H), 2.87 (dd, J = 14.5, 12.1 Hz, 1 H), 2.79 (dd, J = 14.5, 2.3 Hz, 1 H), 1.37
(t, J = 7.2 Hz, 3 H), 1.03 (t, J = 7.2 Hz, 3 H); 13C NMR (100 MHz, CDCl3) 169.6, 167.9, 148.6,
139.6, 135.0, 130.6, 128.6, 128.5, 128.2, 128.0, 127.9, 126.4, 121.5, 115.8, 78.8, 65.8, 62.3, 61.8,
59.3, 31.9, 14.2, 13.7; HRMS C28H29NO5 Calculated = 459.2046, Found = 459.2027
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Dimethyl 2-phenyl-3,6-di-p-tolyl-1,2-oxazinane-4,4-dicarboxylate (35f)
The general Lewis acid cycloaddition procedure was followed using cyclopropane 34b (50 mg,
0.20 mmol), nitrosobenzene (11 mg, 0.10 mmol) and Yb(OTf)3 (12 mg, 0.020 mmol) to yield the
compound as a yellow oil, which was recrystallized with CH2Cl2/Hexane to give a white solid (21
mg, 46%). Rf 0.60 (3:1 Hexanes:EtOAc); 1H NMR (400 MHz, CDCl3) 7.45 - 7.48 (m, 4 H), 7.27
(app d, J = 8.2 Hz, 2 H), 7.07 - 7.14 (m, 4 H), 6.99 (app d, J = 7.8 Hz, 2 H), 6.80 (app tt, J = 8.2,
1.2 Hz, 1 H), 5.76 (s, 1 H), 4.98 (dd, J = 12.1, 2.3 Hz, 1 H), 3.91 (s, 3 H), 3.50 (s, 3 H), 2.86 (dd,
J = 14.5, 12.1 Hz, 1 H), 2.74 (dd, J = 14.5, 2.3 Hz, 1 H), 2.41 (s, 3 H), 2.22 (s, 3 H); 13C NMR (100
MHz, CDCl3) 170.2, 168.4, 148.6, 143.0, 138.2, 137.6, 136.4, 131.9, 130.3, 129.7, 129.5, 129.3,
129.2, 128.7, 128.5, 126.6, 126.5, 121.4, 115.7, 78.7, 65.3, 59.6, 53.4, 52.6, 31.4, 21.3, 21.1;
HRMS C28H29NO5 Calculated = 459.2046, Found = 459.2027

Dimethyl 2-phenyl-3,6-di(thiophen-2-yl)-1,2-oxazinane-4,4-dicarboxylate (35g)
The general Lewis acid cycloaddition procedure was followed using cyclopropane 34e (100 mg,
0.42 mmol), nitrosobenzene (121 mg, 0.20 mmol) and Yb(OTf)3 (12 mg, 0.020 mmol) to yield the
compound as a yellow oil, which was recrystallized with CH2Cl2/Hexane to give a white solid (61
mg, 69%). Rf 0.39 (3:1 Hexanes:EtOAc); 1H NMR (400 MHz, CDCl3) 7.40 (app d, J = 5.1 Hz, 1
H), 7.25 (app d, J = 3.9 Hz, 1 H), 7.15 - 7.20 (m, 3 H), 7.06 - 7.13 (m, 3 H), 6.95 (app d, J = 3.5
Hz, 1 H), 6.88 (app t, J = 7.4 Hz, 1 H), 6.80 - 6.84 (m, 1 H), 6.09 (s, 1 H), 5.27 (dd, J = 12.1, 2.3
Hz, 1 H), 3.92 (s, 3 H), 3.59 (s, 3 H), 2.99 (dd, J = 14.5, 12.1 Hz, 1 H), 2.88 (dd, J = 14.5, 2.3 Hz,
1 H); 13C NMR (100 MHz, CDCl3) 169.3, 167.7, 148.1, 141.5, 133.8, 129.2, 128.5, 127.2, 126.7,
126.0, 125.8, 125.4, 122.4, 116.3, 75.0, 64.3, 59.7, 53.6, 52.9, 32.3; HRMS C22H21NO5S2
Calculated = 443.0861, Found = 443.0864
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Dimethyl 2-(3-bromophenyl)-3,6-diphenyl-1,2-oxazinane-4,4-dicarboxylate (44a)
The general Lewis acid cycloaddition procedure was followed using cyclopropane 34a (100 mg,
0.43 mmol), nitrosoarene (20 mg, 0.11 mmol) and Yb(OTf)3 (6 mg, 0.010 mmol) to yield the
compound as a yellow oil, which was recrystallized with CH2Cl2/Hexane to give a white solid (41
mg, 73%). Rf 0.38 (3:1 Hexanes:EtOAc); 1H NMR (400 MHz, CDCl3) 7.54 - 7.60 (m, 4 H), 7.46
- 7.50 (m, 2 H), 7.40 - 7.43 (m, 1 H), 7.22 - 7.24 (m, 3 H), 6.99 - 7.01 (m, 2 H), 6.91 - 6.94 (m, 1
H), 5.76 (s, 1 H), 4.99 (dd, J = 12.1, 2.3 Hz, 1 H), 3.92 (s, 3 H), 3.49 (s, 3 H), 2.87 (dd, J = 14.5,
12.1 Hz, 1 H), 2.76 (dd, J = 14.5, 2.3 Hz, 1 H); 13C NMR (100 MHz, CDCl3) 169.9, 168.0, 138.9,
134.5, 130.2, 129.9, 128.7, 128.5, 128.3, 128.2, 126.6, 124.4, 122.7, 118.6, 114.0, 79.1, 59.4, 53.6,
52.7; HRMS C26H24BrNO5 Calculated = 509.0838, Found = 509.0823

Dimethyl 2-(4-bromophenyl)-3,6-diphenyl-1,2-oxazinane-4,4-dicarboxylate (44b)
The general Lewis acid cycloaddition procedure was followed using cyclopropane 34a (100 mg,
0.43 mmol), nitrosoarene (37 mg, 0.20 mmol) and Yb(OTf)3 (12 mg, 0.020 mmol) to yield the
compound as a yellow oil, which was recrystallized with CH2Cl2/Hexane to give a white solid (75
mg, 75%). Rf 0.34 (3:1 Hexanes:EtOAc); 1H NMR (400 MHz, CDCl3) 7.53 - 7.57 (m, 4 H), 7.45
- 7.47 (m, 2 H), 7.38 - 7.42 (m, 1 H), 7.18 - 7.20 (m, 5 H), 6.96 - 6.98 (m, 2 H), 5.73 (s, 1 H), 5.00
(dd, J = 12.1, 2.7 Hz, 1 H), 3.92 (s, 3 H), 3.48 (s, 3 H), 2.87 (dd, J = 14.5, 12.1 Hz, 1 H), 2.76 (dd,
J = 14.5, 2.7 Hz, 1 H);

13

C NMR (100 MHz, CDCl3) 168.1, 147.6, 139.0, 134.6, 131.4, 130.3,

128.7, 128.5, 128.3, 128.1, 126.5, 117.5, 114.1, 79.0, 65.6, 59.4, 53.6, 52.7, 31.5; HRMS
C26H24BrNO5 Calculated = 509.0838, Found = 509.0830
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Dimethyl 2-(3-(ethoxycarbonyl)phenyl)-3,6-diphenyl-1,2-oxazinane-4,4-dicarboxylate (44c)
The general Lewis acid cycloaddition procedure was followed using cyclopropane 34a (100 mg,
0.43 mmol), nitrosoarene (39 mg, 0.22 mmol) and Yb(OTf)3 (12 mg, 0.020 mmol) to yield the
compound as a yellow oil, which was recrystallized with CH2Cl2/Hexane to give a white solid (88
mg, 80%). Rf 0.29 (3:1 Hexanes:EtOAc); 1H NMR (400 MHz, CDCl3) 7.75 (app t, J = 1.6 Hz, 1
H), 7.55 - 7.62 (m, 4 H), 7.45 - 7.51 (m, 3 H), 7.39 - 7.43 (m, 1 H), 7.27 - 7.32 (m, 1 H), 7.17 7.22 (m, 4 H), 5.85 (s, 1 H), 5.02 (dd, J = 12.1, 2.3 Hz, 1 H), 4.32 (q, J = 7.0 Hz, 2 H), 3.93 (s, 3
H), 3.49 (s, 3 H), 2.90 (dd, J = 14.5, 12.1 Hz, 1 H), 2.77 (dd, J = 14.5, 2.3 Hz, 1 H), 1.35 (t, J = 7.2
Hz, 3 H);

13

C NMR (100 MHz, CDCl3) 170.0, 168.1, 166.6, 148.6, 139.1, 134.6, 130.4, 128.7,

128.6, 128.4, 128.2, 128.1, 126.5, 122.6, 120.1, 116.6, 79.0, 65.3, 60.9, 59.4, 53.6, 52.7, 31.6, 14.3;
HRMS C29H29NO7 Calculated = 503.1944, Found = 503.1943

Dimethyl 2-(4-(ethoxycarbonyl)phenyl)-3,6-diphenyl-1,2-oxazinane-4,4-dicarboxylate (44d)
The general Lewis acid cycloaddition procedure was followed using cyclopropane 34a (106 mg,
0.45 mmol), nitrosoarene (36 mg, 0.20 mmol) and Yb(OTf)3 (17 mg, 0.027 mmol) to yield the
compound as a yellow oil, which was recrystallized to give a white solid (78 mg, 78%). Rf 0.28
(3:1 Hexanes:EtOAc); 1H NMR (400 MHz, CDCl3) 7.82 - 7.86 (m, 2 H), 7.54 - 7.61 (m, 4 H), 7.46
- 7.51 (m, 2 H), 7.40 - 7.45 (m, 1 H), 7.19 - 7.24 (m, 3 H), 7.09 - 7.13 (m, 2 H), 5.91 (s, 1 H), 5.00
(dd, J = 12.1, 2.3 Hz, 1 H), 4.27 (q, J = 7.0 Hz, 2 H), 3.92 (s, 3 H), 3.50 (s, 3 H), 2.90 (dd, J = 14.5,
12.1 Hz, 1 H), 2.77 (dd, J = 14.5, 2.3 Hz, 1 H), 1.32 (t, J = 7.2 Hz, 3 H); 13C NMR (100 MHz,
CDCl3) 169.9, 168.0, 166.4, 151.9, 138.7, 134.7, 130.6, 130.0, 128.8, 128.6, 128.4, 128.2, 126.6,
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122.8, 114.2, 79.1, 64.4, 60.5, 53.6, 52.8, 31.5, 14.3; HRMS C29H29NO7 Calculated = 503.1944,
Found = 503.1943

Dimethyl 2-(3,4-dichlorophenyl)-3,6-diphenyl-1,2-oxazinane-4,4-dicarboxylate (44e)
The general Lewis acid cycloaddition procedure was followed using cyclopropane 34a (57 mg,
0.24 mmol), nitrosoarene (19 mg, 0.11 mmol) and Yb(OTf)3 (6 mg, 0.010 mmol) to yield the
compound as a yellow oil, which was recrystallized with CH2Cl2/Hexane to give a white solid (50
mg, 91%). Rf 0.55 (3:1 Hexanes:EtOAc); 1H NMR (400 MHz, CDCl3) 7.53 - 7.58 (m, 4 H), 7.46
- 7.50 (m, 2 H), 7.40 - 7.44 (m, 1 H), 7.22 - 7.25 (m, 3 H), 7.17 - 7.19 (m, 2 H), 6.89 - 6.92 (app
dd, J = 9.0, 2.7 Hz, 1 H), 5.72 (s, 1 H), 4.98 (dd, J = 12.3, 2.4 Hz, 1 H), 3.92 (s, 3 H), 3.48 (s, 3 H),
2.87 (dd, J = 14.7, 12.3 Hz, 1 H), 2.74 (dd, J = 14.7, 2.4 Hz, 1 H); 13C NMR (100 MHz, CDCl3)
167.9, 147.9, 138.7, 134.3, 132.5, 130.2, 130.1, 128.8, 128.7, 128.5, 128.3, 126.6, 124.5, 117.5,
114.9, 79.3, 65.3, 59.2, 53.6, 52.8, 31.4; HRMS C26H23Cl2NO5 Calculated = 499.0953, Found =
499.0952

Dimethyl 2-(3-acetylphenyl)-3,6-diphenyl-1,2-oxazinane-4,4-dicarboxylate (44f)
The general Lewis acid cycloaddition procedure was followed using cyclopropane 34a (100 mg,
0.43 mmol), nitrosoarene (32 mg, 0.21 mmol) and Yb(OTf)3 (12 mg, 0.020 mmol) to yield the
compound as a yellow oil, which was recrystallized with CH2Cl2/Hexane to give a white solid (68
mg, 68%). Rf 0.25 (3:1 Hexanes:EtOAc); 1H NMR (400 MHz, CDCl3) 7.64 - 7.67 (m, 1 H), 7.55
- 7.62 (m, 4 H), 7.46 - 7.50 (m, 2 H), 7.39 - 7.43 (m, 2 H), 7.30 - 7.34 (m, 1 H), 7.24 - 7.26 (m, 1
H), 7.18 - 7.22 (m, 3 H), 5.85 (s, 1 H), 5.03 (dd, J = 12.1, 2.3 Hz, 1 H), 3.93 (s, 3 H), 3.49 (s, 3 H),
2.89 (dd, J = 14.5, 12.1 Hz, 1 H), 2.79 (dd, J = 14.5, 2.3 Hz, 1 H), 2.50 (s, 3 H); 13C NMR (100
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MHz, CDCl3) 170.0, 168.1, 148.8, 137.5, 134.6, 130.3, 128.8, 128.7, 128.5, 128.3, 128.1, 126.5,
121.7, 120.5, 115.1, 79.1, 65.3, 59.4, 53.6, 52.7, 31.6, 26.7; HRMS C28H27NO6 Calculated =
473.1838, Found = 473.1829

Dimethyl 2-(1-(tert-butoxycarbonyl)-1H-indol-5-yl)-3,6-diphenyl-1,2-oxazinane-4,4dicarboxylate (44g)
The general Lewis acid cycloaddition procedure was followed using cyclopropane 34a (50 mg,
0.21 mmol), nitrosoarene (27 mg, 0.11 mmol) and Yb(OTf)3 (12 mg, 0.020 mmol) to yield the
compound as a yellow oil, which was recrystallized with CH2Cl2/Hexane to give a white solid (35
mg, 55%). Rf 0.40 (3:1 Hexanes:EtOAc); 1H NMR (400 MHz, CDCl3) 8.04 - 8.06 (m, 1 H), 7.56
- 7.61 (m, 4 H), 7.46 - 7.50 (m, 4 H), 7.39 - 7.42 (m, 1 H), 7.26 - 7.27 (m, 1 H), 7.14 - 7.18 (m, 2
H), 7.10 - 7.13 (app dd, J = 9.0, 2.3 Hz, 1 H), 6.38 (app d, J = 3.5 Hz, 1 H), 5.78 (s, 1 H), 5.10 (dd,
J = 12.1, 2.3 Hz, 1 H), 3.96 (s, 3 H), 3.47 (s, 3 H), 2.90 (dd, J = 14.5, 12.1 Hz, 1 H), 2.80 (dd, J =
14.5, 2.3 Hz, 1 H), 1.61 (s, 9 H); 13C NMR (100 MHz, CDCl3) 170.2, 168.3, 166.2, 144.5, 139.6,
134.9, 131.0, 130.5, 128.8, 128.6, 128.4, 128.3, 128.0, 127.9, 126.6, 114.9, 107.4, 78.8, 67.3, 59.6,
53.8, 53.5, 52.6, 31.7, 28.2; HRMS C33H34N2O7 Calculated = 570.2366, Found = 570.2347

General Lewis Acid Catalyzed Cross-Over Experiment Procedure
To a solution of cyclopropane 34a (0.43 mmol, 1.0 equiv) and cyclopropane 34d (0.43
mmol, 1.0 equiv) and nitrosobenzene 32a (0.43 mmol, 1.0 equiv) in DCE (3 mL) was added
Yb(OTf)3 (0.043 mmol, 0.1 equiv) and stirred for 15 min. The mixture was heated to reflux for 3
h then concentrated after consumption of cyclopropane (as indicated by TLC) and directly loaded
onto a packed SiO2 column. The products were purified by flash chromatography (9:1
hexanes/EtOAc).
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Chapter 3 - Cycloadditions of Donor-Acceptor Cyclopropanes with Azo Dicarboxylates

3.1 Introduction
In 2007, Armin de Meijer reported the successful reaction between cyclopropanes and azo
dicarboxylates, which give rise to pyrazolidine derivatives (Scheme 3.1). After testing several
Lewis acids, GaCl3 was found to catalyze the reaction, and only trace amounts of product were
formed using Yb(OTf)3. When trans-configured diazenes are used, insertion into the cyclopropane
ring proceeds with complete regioselectivity to produce the expected 5-arylpyrazolidine-1,2,3,3tetracarboxylates. The trans-configured diazenes used were naturally existing mixtures of minor
amounts of cis- and major amounts of the thermodynamically favoured trans-diastereomers. The
reactivity of cyclopropanes towards a fixed cis-configuration of the N,N double bond was also
investigated. Interestingly, when 4-phenyl-1,2,4-triazoline-3,5-dione (PTAD) was used as a cisconfigured diazene, two possible regioisomeric pyrazolidine derivatives were formed in ratios
varying from 1:1.5 to 1:3.22

Scheme 3.1 Cycloaddition of DA cyclopropanes with azo dicarboxylates
3.2 Cycloadditions of DA Cyclopropanes with trans-Diazenes
The [3+2] cycloaddition reaction of cyclopropanes with trans-configured diazenes as seen
in Scheme 3.2 was examined in order to investigate the mechanism and hopefully provide a deeper
understanding of how cyclopropanes react with nitrogen-heteroatom double bonded compounds.
This mode of reactivity may show resemblance to the opening of cyclopropanes with
nitrosoarenes, so a cross-over experiment was performed in order to probe the mechanism of the
following reaction.

33

Scheme 3.2 Cycloaddition of DA cyclopropanes with trans-diazenes
3.2.1 Cross-Over Experiment #2
To obtain experimental evidence that trans-configured diazenes open the cyclopropane
ring in a nucleophilic manner, paralleling what happens with nitrosoarenes, a cross-over
experiment would have to contain two different cyclopropanes in order to show that a cross-over
event occurred. For this cross-over experiment, four different cyclopropanes were used so that four
different pyrazolidine standards could be generated, accounting for the possible cross-over based
products (Table 3.1). After obtaining the four pyrazolidine standards, the cross-over experiment
was performed and the reaction mixture was analyzed.
Table 3.1 Cycloaddition of DA cyclopropanes with trans-diazenes

Entrya

a

Cyclopropane

Product

Yield (%)b

1

Ar = C6H5, R = Me

48a

58

2

Ar = 4-MeC6H4, R = Me

48b

50

3

Ar = C6H5, R = Et

48c

23

4

Ar = 4-MeC6H4, R = Et

48d

52

Typical reaction conditions: To a solution of GaCl3 in CH2Cl2 (0.8 mL) at room

temperature, was added cyclopropane (0.21 mmol) and trans-diazene (0.29 mmol).
Reactions were monitored by TLC until cyclopropane was consumed.
yield.

b

Isolated

34

Separation of the reaction mixture was performed using column chromatography and only
two products had formed, as seen in Scheme 3.3.

Scheme 3.3 Cross-over experiment of DA cyclopropanes with trans-diazenes
The expected [3+2] cycloaddition products were observed with no cross-over. This
provides evidence of a straight forward [3+2] cycloaddition with nothing unusual observed with
trans-diazenes.
3.3 Cycloadditions of DA Cyclopropanes with cis-Diazenes
The cycloaddition product from DA cyclopropane and cis-configured diazene PTAD
produces an unusual pyrazolidine derivative, which may have arisen from insertion into the C(2)C(3) bond of the cyclopropane (Scheme 3.4). Because of this surprisingly different mode of
cyclopropane reactivity, the reaction of DA cyclopropanes with trans-diazenes must operate
through a different type of mechanism than cis-diazenes. A cross-over experiment was performed
to investigate how this unusual pyrazolidine derivative product was formed. Understanding how
cyclopropanes can undergo this rare insertion into the C(2)-C(3) bond would be useful for its
application in synthesis.

Scheme 3.4 Cycloaddition of DA cyclopropanes with cis-diazenes
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A mechanism was proposed by de Meijer to account for the unusual reactivity of the DA
cyclopropane when it encounters the Lewis activated cis-diazene (Figure 3.1). It would be very
difficult to prove how this reaction proceeds without the use of a cross-over experiment.

Figure 3.1 Proposed mechanism for the cycloaddition of DA cyclopropane with cis-diazene
PTAD was synthesized according to Scheme 3.5 for use in a cross-over experiment and
also to generating standards used to analyze the reaction mixture.

Scheme 3.5 Synthesis of PTAD
The cycloaddition of DA cyclopropanes with cis-diazenes was investigated so that it may
be applied to understanding and advancing the nitrosoarene chemistry if experimental evidence
suggests similarities. Possible reaction mechanisms that accounts for both products are shown in
Scheme 3.6 and 3.7, demonstrating a possible resemblance to the cycloaddition of DA
cyclopropanes with nitrosoarene mechanism. The first mechanism shows the cycloaddition leading
to the minor product operating through a step-wise sequence.
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Scheme 3.6 Proposed mechanism for the formation of minor product 50a

Scheme 3.7 Proposed mechanism for the formation of major product 51a
Co-ordination of Yb(OTf)3 to the di-ester group on the cyclopropane may allow for a
nucleophilic ring opening attack from a nitrogen in PTAD. The mechanism in scheme 3.6 shows
formation of the minor product going through a step-wise cyclization, once the acyclic zwitterionic
intermediate is formed. Because the presented cyclization is going through a 5-Endo-Trig reaction,
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which is disallowed according to Baldwin’s rules, the cyclization may be going through a
concerted cycloaddition. Scheme 3.7 and 3.8 illustrate that production of the major product may
occur through the formation of an azomethine imine intermediate (57).
The formation of azomethine imines through the reaction of DA cyclopropanes with cisdiazenes has been of interest in the Pagenkopf group and experimental evidence supporting this
theory would be of interest not only for understanding the reaction, but in the future development
of new reaction types and reaction partners with DA cyclopropanes.

Scheme 3.8 Formation of the two different pyrazolidine regio-isomers
Major product 51a must be coming from azomethine imine 57, which would have a slightly
higher degree of stability or population in comparison to the resonance structure 57a (Scheme 3.8).
The resonance structure, in which the negative charge ends up on nitrogen instead of carbon, would
be the more favoured intermediate (57) and would therefore contribute to the major product, which
is observed to be the case. A resonance structure that places a negative charge on carbon of the
azomethine imine (57a) is possible, but is not considered to be a nucleophilic centre based on the
regio-selectivity of other observed azomethine imine reactions. It is therefore highly unlikely that
the minor product would be occurring through this type of pathway, and is most likely the result
of a formal [3+2] cycloaddition with azomethine imine 57.
This mode of reactivity would require only one equivalent of DA cyclopropane to one
equivalent of the cis-diazene because the α,β-unsaturated di-ester may be incorporated into the
product. This is slightly different than the nitrosoarene reaction with DA cyclopropanes, because
the α,β-unsaturated di-ester is just a by-product and is not incorporated into the tetrahydro-1,2oxazine product. It is worth determining if the minor product is formed from incorporation of the
α,β-unsaturated di-ester unit, or if it is simply a straight-forward cyclization as presented in scheme
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2.6. The use of a cross-over experiment would be of great benefit in helping to answer how the
two different regio-isomers are formed.
Understanding the different ways that DA cyclopropanes react with various dipolarophiles
has been undertaken with the hope of developing better and more efficient methods of generating
diverse heterocycles. Developing reactions than are able to insert different functional groups into
the C(2)-C(3) bond of the cyclopropane ring would have many advantages, and understanding this
rare type of reactivity is currently being investigated with the use of cross-over experiments. Being
able to open the cyclopropane ring in a controlled manner that allows for different regio-isomers
to from is attractive and expands the use of DA cyclopropanes in synthetic chemistry.
3.3.1 Cross-over Experiment #3
Two different cyclopropanes were used as starting material and reacted with PTAD under
GaCl3 catalytic conditions (Scheme 3.9). The production of a cross-over based pyrazolidine
product would give information about how this reaction mechanism is happening. If results show
the presence of a pyrazolidine product, in which cross-over has occurred, then the reaction may be
taking place in a way that is similar to the cycloaddition of DA cyclopropanes with nitrosoarenes
reaction.

Scheme 3.9 Cross-over experiment of DA cyclopropanes with cis-diazenes
The four products shown in Figure 3.2 are expected to be in the reaction mixture of the
cross-over experiment. These products would arise from the known reactivity of the two DA
cyclopropanes reacting with PTAD, and show no crossing-over.
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Figure 3.2 Expected products from the cross-over experiment
If additional products are formed, showing that cross-over had occurred, then this provides
mechanistic information that would be helpful in generating a theoretical mechanism with
supporting evidence. Formation of any of the products shown in Figure 3.3 would be the result of
a cross-over event happening in the reaction.

Figure 3.3 Proposed cross-over based products from the cross-over experiment
If DA cyclopropanes react with nitrosoarenes and cis-diazenes in a similar fashion, in
which a nitrogen-heteroatom double bond opens up the cyclopropane ring, and can be reinforced
with experimental evidence, then other reaction types may be discovered by investigating this
mode of reactivity. I synthesized the required pyrazolidine standards individually using the
methodology presented in de Meijer’s study. Table 3.2 shows the synthesis of 8 pyrazolidine
standards, which were then used as authentic standards in cross-over experiment #3.
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Table 3.2 Synthesis of pyrazolidine standards

Entrya

a

Cyclopropane

Product

Yield (%)b

1

Ar = C6H5, R = Me

50a

13

2

Ar = C6H5, R = Me

51a

20

3

Ar = C6H5, R = Et

50b

19

4

Ar = C6H5, R = Et

51b

22

5

Ar = 4-MeC6H4, R = Me

50c

21

6

Ar = 4-MeC6H4, R = Me

51c

12

7

Ar = 4-MeC6H4, R = Et

50d

12

8

Ar = 4-MeC6H4, R = Et

51d

12

Typical reaction conditions: GaCl3 was added to a solution of cyclopropane

(0.21 mmol) and PTAD (0.21 mmol) in CH2Cl2 (0.2 mL). Reactions were
monitored by TLC. b Isolated yield.

A detailed analysis of the products from cross-over experiment #3, as seen in Figure 3.4,
was achieved with the use of NMR and GC-MS. After carefully analyzing the reaction mixture of
the cross-over experiment, it was revealed that all four expected products were formed and, in
addition, two of the cross-over products were also formed, yielding six products in total.
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Figure 3.4 Results of cross-over experiment #3

Formation of the cross-over based products provide key mechanistic information that is in
agreement with the reaction proceeding via an azomethine imine as illustrated in Scheme 3.7. The
azomethine imine can react with either the dimethyl or diethyl α,β-unsaturated ester to yield 51c
or 51b, respectively. The absence of the other cross-over based products from the reaction mixture
is in agreement with the proposed mechanism.
3.3.2 Cross-over Experiment #3 Reversed

To achieve additional supporting evidence, the reaction was run in reverse, starting with
cross-over based cyclopropanes (Scheme 3.10) and observing the reaction mixture to see if crossover was happening in a reproducible event. The reverse cross-over experiment was repeated three
times to provide reinforcing data, as seen in Figure 3.5. This generated reproducible results that
are in agreement with the original proposed mechanism.
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Scheme 3.10 Reversed cross-over experiment of DA cyclopropanes with cis-diazenes

Figure 3.5 Results of reversed cross-over experiment #3

The results from cross-over experiments 1 and 3 (Scheme 3.11 and 3.12) show similarities
in the reaction of 1,1-cyclopropane diesters with nitrosoarenes and cis-diazenes. The overall
pattern of reactivity is the same as both reactions led to the production of a 1,3-dipole intermediate.
In the case of nitrosoarenes, a nitrone was produced. In the case of cis-diazenes, an azomethine
imine was produced. In both cases the functional group is a nitrogen-heteroatom double bond, with
a lone pair on nitrogen attacking as a nucleophile to open up the activated DA cyclopropane. The
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resulting intermediate undergoes fragmentation forming a 1,3-dipole and an α,β-unsaturated
diester.

Scheme 3.11 Reaction of nitrosoarenes and cis-diazenes with DA cyclopropanes

Scheme 3.12 Mechanistic formation of 1,3-dipoles
Additional experimentation may show that other heteroatoms could react in a similar
fashion, paving the way for new reactions and other reaction partners for DA cyclopropanes. In
the case of nitrogen, which is a Group 5 element, trying elements in the same column such as
phosphorus, may lead to new reactions because of similarities in the electronic structure of the two
elements.
A potential avenue for investigation could include obtaining a compound with a nitrogenphosphorus double bond and observing the ability of the sp2 hybridized nitrogen to undergo
nucleophilic opening of a DA cyclopropane ring, followed by fragmentation into a 1,3-dipole and
an α,β-unsaturated diester. A proper Lewis Acid would be needed to activate the DA cyclopropane,
with the idea of undergoing a reaction similar to Scheme 3.12, except using X = phosphorus.
Another experiment could attempt trying elements in the same column as oxygen, such as
sulfur. Obtaining a compound with a nitrogen-sulfur double bond would allow for reactions to
study the nucleophilicity of the sp2 hybridized nitrogen towards the opening of DA cyclopropane
rings upon activation by Lewis Acids, similar to Scheme 2.12, except using X = sulfur.
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3.4 Experimental
The procedures and conditions were the same as described in section 2.3.
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3.5 Supporting Information
General trans-Diazene Cycloaddition Procedure
To a solution of cyclopropane (0.21 mmol, 1.0 equiv) and diisopropyl azodicarboxylate
(0.29 mmol, 1.4 equiv) in CH2Cl2 (0.2 mL) was added a solution of GaCl3 (0.04 mmol, 0.2 equiv)
in CH2Cl2 (0.8 mL). After stirring for 3 h, the crude mixture was concentrated and directly loaded
onto a packed SiO2 column. Product was purified by flash chromatography (8:1 hexanes/EtOAc)
to afford the corresponding cycloadducts.

1,2-Diisopropyl 3,3-dimethyl 5-phenylpyrazolidine-1,2,3,3-tetracarboxylate (48a)
The general trans-diazene cycloaddition procedure was followed using cyclopropane 34a (50 mg,
0.21 mmol), diisopropyl azodicarboxylate 47 (59 mg, 0.29 mmol) and GaCl3 (7 mg, 0.040 mmol)
to yield the compound as a yellow oil (53 mg, 58%). Rf 0.22 (3:1 Hexanes:EtOAc); 1H NMR (400
MHz, CDCl3) 7.39 (app d, J = 7.8 Hz, 2 H), 7.29 - 7.34 (m, 2 H), 7.22 - 7.26 (m, 1 H), 5.46 (dd, J
= 8.2, 3.9 Hz, 1 H), 5.02 (hept, J = 6.3 Hz, 1 H), 4.97 (hept, J = 6.3 Hz, 1 H), 3.82 (s, 3 H), 3.47
(s, 3 H), 3.30 (dd, J = 13.3, 8.2 Hz, 1 H), 2.92 (dd, J = 13.3, 3.9 Hz, 1 H), 1.24 - 1.30 (m, 12 H);
13

C NMR (100 MHz, CDCl3) 168.8, 166.5, 156.9, 153.3, 139.5, 128.3, 127.3, 125.8, 72.4, 70.8,

70.5, 61.2, 53.4, 53.0, 44.7, 22.1, 21.9; HRMS C21H28N2O8 Calculated = 436.1846, Found =
436.1841
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1,2-Diisopropyl 3,3-dimethyl 5-p-tolylpyrazolidine-1,2,3,3-tetracarboxylate (48b)
The general trans-diazene cycloaddition procedure was followed using cyclopropane 34b (55 mg,
0.22 mmol), diisopropyl azodicarboxylate 47 (63 mg, 0.31 mmol) and GaCl3 (7 mg, 0.040 mmol)
to yield the compound as a yellow oil (50 mg, 50%). Rf 0.25 (3:1 Hexanes:EtOAc); 1H NMR (400
MHz, CDCl3) 7.27 (app d, J = 8.2 Hz, 2 H), 7.12 (app d, J = 8.2 Hz, 2 H), 5.40 (dd, J = 8.2, 4.3
Hz, 1 H), 5.01 (hept, J = 6.3 Hz, 1 H), 4.98 (hept, J = 6.3 Hz, 1 H), 3.82 (s, 3 H), 3.51 (s, 3 H),
3.27 (dd, J = 13.3, 8.2 Hz, 1 H), 2.90 (dd, J = 13.3, 4.3 Hz, 1 H), 2.32 (s, 3 H), 1.24 - 1.30 (m, 12
H);

13

C NMR (100 MHz, CDCl3) 168.8, 166.4, 156.9, 153.4, 136.9, 136.5, 129.0, 125.8, 72.5,

70.7, 70.5, 61.0, 53.4, 53.0, 44.7, 22.1, 21.9; HRMS C22H30N2O8 Calculated = 450.2002, Found =
450.1999

3,3-Diethyl 1,2-diisopropyl 5-phenylpyrazolidine-1,2,3,3-tetracarboxylate (48c)
The general trans-diazene cycloaddition procedure was followed using cyclopropane 34c (50 mg,
0.19 mmol), diisopropyl azodicarboxylate 47 (55 mg, 0.27 mmol) and GaCl3 (7 mg, 0.040 mmol)
to yield the compound as a yellow oil (20 mg, 23%). Rf 0.30 (3:1 Hexanes:EtOAc); 1H NMR (400
MHz, CDCl3) 7.38 - 7.42 (m, 2 H), 7.29 - 7.33 (m, 2 H), 7.22 - 7.25 (m, 1 H), 5.50 (dd, J = 8.2,
3.5 Hz, 1 H), 5.02 (hept, J = 6.3 Hz, 1 H), 4.98 (hept, J = 6.3 Hz, 1 H), 4.29 (dddd, J = 7.0, 7.0,
7.0, 10.5 Hz, 2 H), 3.90 (dddd, J = 7.2, 7.2, 7.2, 10.8 Hz, 2 H), 3.33 (dd, J = 13.3, 8.6 Hz, 1 H),
2.90 (dd, J = 13.3, 3.1 Hz, 1 H), 1.24 - 1.34 (m, 15 H), 0.91 (t, J = 7.0 Hz, 3 H); 13C NMR (100
MHz, CDCl3) 168.2, 166.2, 156.9, 153.1, 139.7, 128.3, 127.2, 125.8, 72.3, 70.8, 70.4, 62.4, 62.1,
61.2 44.5, 22.1, 21.9, 21.7, 14.0, 13.3; HRMS C23H32N2O8 Calculated = 464.2159, Found =
464.2167
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3,3-Diethyl 1,2-diisopropyl 5-(p-tolyl)pyrazolidine-1,2,3,3-tetracarboxylate (48d)
The general trans-diazene cycloaddition procedure was followed using cyclopropane 34d (50 mg,
0.18 mmol), diisopropyl azodicarboxylate 47 (51 mg, 0.25 mmol) and GaCl3 (6 mg, 0.036 mmol)
to yield the compound as a yellow oil (45 mg, 52%). Rf 0.31 (3:1 Hexanes:EtOAc); 1H NMR (400
MHz, CDCl3) 7.28 (app d, J = 8.2 Hz, 2 H), 7.11 (app d, J = 8.2 Hz, 2 H), 5.45 (dd, J = 8.2, 3.5
Hz, 1 H), 5.01 (hept, J = 6.3 Hz, 1 H), 4.97 (hept, J = 6.3 Hz, 1 H), 4.28 (dddd, J = 7.0, 7.0, 7.0,
10.5 Hz, 2 H), 3.93 (dddd, J = 7.2, 7.2, 7.2, 10.8 Hz, 2 H), 3.29 (dd, J = 13.3, 8.2 Hz, 1 H), 2.88
(dd, J = 13.3, 3.5 Hz, 1 H), 2.31 (s, 3 H), 1.23 - 1.34 (m, 15 H), 0.95 (t, J = 7.0 Hz, 3 H); 13C NMR
(100 MHz, CDCl3) 168.2, 166.2, 156.9, 153.2, 136.8, 136.7, 128.9, 125.8, 72.4, 70.7, 70.3, 62.4,
62.2, 61.0, 44.5, 22.1, 21.9, 21.0, 14.0, 13.3; HRMS C24H34N2O8 Calculated = 478.2315, Found =
478.2321

(PTAD) 4-Phenyl-1,2,4-trizaoline-3,5-dione (49)
tert-Butyl hypochlorite (130 mg, 1.2 mmol, 1.1 equiv) was added drop wise with stirring to a
solution of 4-phenyl-1,2,4-trizaolidine-3,5-dione (200 mg, 1.1 mmol, 1.0 equiv) in 1,4-dioxane (5
mL). After 30 min the solvent was removed under reduced pressure keeping the temp below 40°C
to yield the product as a red solid (200 mg, 99%). 1H NMR (400 MHz, CDCl3) 7.46 - 7.59 (m, 5
H); 13C NMR (100 MHz, CDCl3) 129.9, 129.5, 123.9
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General cis-Diazene Cycloaddition Procedure
To a solution of cyclopropane (0.85 mmol, 1.0 equiv) and PTAD (1.7 mmol, 2.0 equiv) in
CH2Cl2 (4.0 mL) was added a solution of GaCl3 (0.17 mmol, 0.2 equiv) in CH2Cl2 (1.0 mL). After
stirring for 3 h, the crude mixture was concentrated and directly loaded onto a packed SiO2 column.
Product was purified by flash chromatography (8:1 hexanes/EtOAc) to afford the corresponding
cycloadducts.

Dimethyl 1,3-dioxo-2,7-diphenyltetrahydropyrazolo[1,2-a][1,2,4]triazole-5,5(1H)dicarboxylate (50a)
The general cis-diazene cycloaddition procedure was followed using cyclopropane 34a (200 mg,
0.85 mmol), cis-diazene 49 (298 mg, 1.7 mmol) and GaCl3 (30 mg, 0.17 mmol) to yield the
compound as a white solid (45 mg, 13%). Rf 0.40 (3:1 Hexanes:EtOAc); 1H NMR (400 MHz,
CDCl3) 7.51 - 7.55 (m, 2 H), 7.33 - 7.47 (m, 8 H), 5.19 (dd, J = 9.0, 7.4 Hz, 1 H), 3.92 (s, 3 H),
3.87 (s, 3 H), 3.28 (d, J = 3.1 Hz, 1 H), 3.25 (d, J = 5.1 Hz, 1 H); 13C NMR (100 MHz, CDCl3)
167.0, 165.7, 153.6, 136.6, 131.5, 129.1, 128.7, 128.3, 126.2, 125.7, 70.7, 59.3, 54.4, 54.0, 46.9;
HRMS C21H19N3O6 Calculated = 409.1274, Found = 409.1264
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Dimethyl 1,3-dioxo-2,5-diphenyltetrahydropyrazolo[1,2-a][1,2,4]triazole-6,6(1H)dicarboxylate (51a)
The general cis-diazene cycloaddition procedure was followed using cyclopropane 34a (200 mg,
0.85 mmol), cis-diazene 49 (298 mg, 1.7 mmol) and GaCl3 (30 mg, 0.17 mmol) to yield the
compound as a white solid (71 mg, 20%). Rf 0.45 (3:1 Hexanes:EtOAc); 1H NMR (400 MHz,
CDCl3) 7.48 - 7.50 (m, 4 H), 7.32 - 7.42 (m, 6 H), 5.85 (s, 1 H), 4.46 (d, J = 13.3 Hz, 1 H), 4.28
(d, J = 13.3 H, 1 H), 3.81 (s, 3 H), 3.47 (s, 3 H); 13C NMR (100 MHz, CDCl3) 169.7, 164.8, 156.6,
156.3, 134.9, 131.6, 129.2, 129.1, 128.7, 128.5, 127.3, 126.0, 66.0, 65.3, 54.1, 52.8, 49.8; HRMS
C21H19N3O6 Calculated = 409.1274, Found = 409.1264

Diethyl 1,3-dioxo-2,7-diphenyltetrahydropyrazolo[1,2-a][1,2,4]triazole-5,5(1H)dicarboxylate (50b)
The general cis-diazene cycloaddition procedure was followed using cyclopropane 34c (50 mg,
0.19 mmol), cis-diazene 49 (67 mg, 0.38 mmol) and GaCl3 (7 mg, 0.040 mmol) to yield the
compound as a white solid (16 mg, 19%). Rf 0.60 (1:1 Hexanes:EtOAc); 1H NMR (600 MHz,
CDCl3) 7.51 - 7.54 (m, 2 H), 7.43 - 7.45 (m, 4 H), 7.39 - 7.41 (m, 2 H), 7.33 - 7.36 (m, 2 H), 5.16
(dd, J = 9.4, 7.6 Hz, 1 H), 4.37 (dddd, J = 7.0, 7.0, 7.0, 10.5 Hz, 2 H), 4.33 (q, J = 7.0 Hz, 2 H),
3.27 (dd, J = 13.5, 7.6 Hz, 1 H), 3.25 (dd, J = 13.5, 8.8 Hz, 1 H), 1.33 (t, J = 7.0 Hz, 3 H), 1.31 (t,
J = 7.0 Hz, 3 H); 13C NMR (100 MHz, CDCl3) 166.6, 165.1, 153.5, 153.2, 136.8, 131.6, 129.1,
129.0, 128.7, 128.2, 126.2, 125.7, 70.9, 63.8, 63.3, 59.2, 46.8, 14.0, 13.9; HRMS C23H23N3O6
Calculated = 437.1587, Found = 437.1582
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Diethyl 1,3-dioxo-2,5-diphenyltetrahydropyrazolo[1,2-a][1,2,4]triazole-6,6(1H)dicarboxylate (51b)
The general cis-diazene cycloaddition procedure was followed using cyclopropane 34c (50 mg,
0.19 mmol), cis-diazene 49 (67 mg, 0.38 mmol) and GaCl3 (7 mg, 0.040 mmol) to yield the
compound as a white solid (18 mg, 22%). Rf 0.70 (1:1 Hexanes:EtOAc); 1H NMR (600 MHz,
CDCl3) 7.45 - 7.51 (m, 4 H), 7.35 - 7.40 (m, 6 H), 5.84 (s, 1 H), 4.47 (d, J = 12.9 Hz, 1 H), 4.31
(d, J = 12.9 Hz, 1 H), 4.23 - 4.31 (m, 2 H), 3.99 (dddd, J = 7.3, 7.3, 7.3, 10.9 Hz, 1 H), 3.83 (dddd,
J = 7.0, 7.0, 7.0, 10.5 Hz, 1 H), 1.25 (t, J = 7.0 Hz, 3 H), 1.07 (t, J = 7.0 Hz, 3 H); 13C NMR (100
MHz, CDCl3) 164.4, 156.5, 135.1, 129.2, 129.0, 128.6, 128.4, 127.5, 125.9, 81.3, 65.9, 63.3, 62.2,
49.8, 13.8, 13.6; HRMS C23H23N3O6 Calculated = 437.1587, Found = 437.1591

Dimethyl 1,3-dioxo-2-phenyl-7-(p-tolyl)tetrahydropyrazolo[1,2-a][1,2,4]triazole-5,5(1H)dicarboxylate (50c)
The general cis-diazene cycloaddition procedure was followed using cyclopropane 34b (50 mg,
0.20 mmol), cis-diazene 49 (70 mg, 0.40 mmol) and GaCl3 (7 mg, 0.040 mmol) to yield the
compound as a white solid (18 mg, 21%). Rf 0.65 (1:1 Hexanes:EtOAc); 1H NMR (600 MHz,
CDCl3) 7.50 - 7.53 (m, 2 H), 7.42 - 7.45 (m, 2 H), 7.33 - 7.36 (m. 1 H), 7.32 (app d, J = 7.6 Hz, 2
H), 7.20 (app d, J = 7.6 Hz, 2 H), 5.14 (dd, J = 8.2, 8.2 Hz, 1 H), 3.91 (s, 3 H), 3.87 (s, 3 H), 3.25
(d, J = 8.2 Hz, 2 H), 2.35 (s, 3 H); 13C NMR (100 MHz, CDCl3) 167.0, 165.8, 153.5, 138.6, 131.6,
129.7, 129.0, 128.2, 126.2, 125.7, 70.6, 59.2, 54.3, 54.0, 46.9, 21.1; HRMS C22H21N3O6 Calculated
= 423.1430, Found = 423.1431
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Dimethyl 1,3-dioxo-2-phenyl-5-(p-tolyl)tetrahydropyrazolo[1,2-a][1,2,4]triazole-6,6(1H)dicarboxylate (51c)
The general cis-diazene cycloaddition procedure was followed using cyclopropane 34b (50 mg,
0.20 mmol), cis-diazene 49 (70 mg, 0.40 mmol) and GaCl3 (7 mg, 0.040 mmol) to yield the
compound as a white solid (10 mg, 12%). Rf 0.72 (1:1 Hexanes:EtOAc); 1H NMR (600 MHz,
CDCl3) 7.48 - 7.49 (m, 4 H), 7.38 - 7.41 (m, 1 H), 7.17 - 7.23 (m, 4 H), 5.81 (s, 1 H), 4.46 (d, J =
12.9 Hz, 1 H), 4.30 (d, J = 12.9 Hz, 1 H), 3.80 (s, 3 H), 3.49 (s, 3 H), 2.34 (s, 3 H); 13C NMR (100
MHz, CDCl3) 169.7, 164.9, 156.2, 139.0, 131.9, 131.6, 129.3, 129.2, 128.4, 127.2, 125.9, 65.9,
65.2, 54.0, 52.8, 49.8, 21.2; HRMS C22H21N3O6 Calculated = 423.1430, Found = 423.1431

Diethyl 1,3-dioxo-2-phenyl-7-(p-tolyl)tetrahydropyrazolo[1,2-a][1,2,4]triazole-5,5(1H)dicarboxylate (50d)
The general cis-diazene cycloaddition procedure was followed using cyclopropane 34d (50 mg,
0.18 mmol), cis-diazene 49 (63 mg, 0.36 mmol) and GaCl3 (6 mg, 0.036 mmol) to yield the
compound as a white solid (10 mg, 12%). Rf 0.60 (5:1 Et2O:Pentane); 1H NMR (400 MHz, CDCl3)
7.50 - 7.54 (m, 2 H), 7.42 - 7.46 (m, 2 H), 7.33 - 7.37 (m, 3 H), 7.21 (app d, J = 7.8 Hz, 2 H), 5.13
(dd, J = 8.4, 8.4 Hz, 1 H), 4.30 - 4.44 (m, 4 H), 3.24 (d, J = 8.6 Hz, 2 H), 2.35 (s, 3 H), 1.33 (t, J =
7.0 Hz, 3 H), 1.32 (t, J = 7.0 Hz, 3 H); 13C NMR (100 MHz, CDCl3) 166.6, 165.2, 153.5, 153.2,
138.6, 133.7, 131.6, 129.7, 129.0, 128.2, 126.2, 125.7, 70.8, 63.8, 63.3, 59.1, 46.8, 21.2, 14.0, 13.9;
HRMS C24H25N3O6 Calculated = 451.1743, Found = 451.1733
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Diethyl 1,3-dioxo-2-phenyl-5-(p-tolyl)tetrahydropyrazolo[1,2-a][1,2,4]triazole-6,6(1H)dicarboxylate (51d)
The general cis-diazene cycloaddition procedure was followed using cyclopropane 34d (50 mg,
0.18 mmol), cis-diazene 49 (63 mg, 0.36 mmol) and GaCl3 (6 mg, 0.036 mmol) to yield the
compound as a white solid (10 mg, 12%). Rf 0.70 (5:1 Et2O:Pentane); 1H NMR (400 MHz, CDCl3)
7.45 - 7.52 (m, 4 H), 7.34 - 7.41 (m, 1 H), 7.23 - 7.25 (m, 2 H), 7.16 - 7.18 (m, 2 H), 5.81 (s, 1 H),
4.46 (d, J = 13.3 Hz, 1 H), 4.23 - 4.31 (m, 3 H), 3.98 - 4.06 (m, 1 H), 3.80 - 3.88 (m, 1 H), 2.34 (s,
3 H), 1.25 (t, J = 7.0 Hz, 3 H), 1.10 (t, J = 7.2 Hz, 3 H); 13C NMR (100 MHz, CDCl3) 169.4, 164.5,
156.5, 156.2, 138.9, 132.0, 131.6, 129.3, 129.2, 128.4, 127.3, 125.9, 120.7, 65.7, 65.4, 63.3, 62.2,
49.8, 21.2, 13.9, 13.6; HRMS C24H25N3O6 Calculated = 451.1743, Found = 451.1733
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Chapter 4 - Cycloadditions of Donor-Acceptor Cyclobutanes with cis-Diazenes

4.1 Introduction
Cyclobutanes have been utilized for various synthetic uses such as ring expansions,23
metal-catalyzed activation of the carbon-carbon bonds,24 and Baeyer Villiger oxidations.25
Because of the unique properties present in cyclobutanes, such as a highly strained ring system,
they have been modified into Donor-Acceptor (DA) cyclobutanes in a similar way to DA
cyclopropanes. Because the cyclobutane ring system contains four carbon atoms, a 1,4-dipole
equivalent (59) may be generated under the appropriate conditions as seen in Scheme 4.1.

Scheme 4.1 Reactivity of DA cyclobutanes

The use of DA cyclobutanes has received less attention than DA cyclopropanes, with the
use of DA cyclobutanes starting around 1986.26 This work later led to the application of DA
cyclobutanes in cycloaddition chemistry with seminal work done by Saigo in 1991.27 Saigo
reported that amino-activated cyclobutane mono-ester (60) reacted with aldehydes or ketones
when treated with TiCl4 to furnish tetrahydropyrans (62) in moderate yields and poor
diastereoselectivity (Scheme 4.2).

Scheme 4.2 Cycloaddition or DA cyclobutane with aldehydes or ketones
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4.1.1 Alkoxy-Activated Cyclobutane Diesters

The Pagenkopf group began experimenting with alkoxy-activated cyclobutane diesters in
2010 because of the similarities to DA cyclopropanes, which have been a focus of interest in the
group.28 Reacting DA cyclobutanes with various dipolarophiles began with first with imines,
which was followed by aldehydes. Further work included reacting DA cyclobutanes with
acetylenes and nitrones (Scheme 4.3).

Scheme 4.3 Pagenkopf research of DA cyclobutanes

Under Yb(OTf)3 catalysis, DA cyclobutanes undergo a formal [4+2] cycloaddition with
imines to form piperidines (64) in a stereoselective manner. A similar type of formal [4+2]
cycloaddition is also possible when aldehydes are used as the dipolarophile, and produce
tetrahydropyrans (63) again in a stereoselective manner.29 Both of these reactions were discovered
in 2010 and it was quickly realized that other dipolarophiles would react in a similar way. In 2011,
the formal [4+3] cycloaddition between DA cyclobutanes and nitrones was discovered. This
reaction led to oxazepines (65) with stereochemistry that can be controlled based on reaction
conditions.30 In the same year it was also discovered that terminal alkynes reacted with DA
cyclobutanes in the presence of BF3·OEt2 as the Lewis acid to generate dihydrooxepines (66).31
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4.1.2 Synthesis of DA Cyclobutanes

To begin exploring the possibility of cycloadditions occurring between DA cyclobutanes
and cis-diazenes, it was necessary to work with the appropriate starting materials. The Pagenkopf
group’s success with alkoxy-activated cyclobutane diesters in other cycloaddition reactions
determined them to be a good choice for the DA cyclobutane. The required alkoxy-activated
cyclobutane diester was synthesized through a two-step procedure that began with a Knoevenagel
condensation of diethyl malonate (68) with paraformaldehyde to generate the highly reactive
methylidene malonate (69). The malonate was then treated with dihydrofuran (70) under Zn(OTf)2
catalyzed conditions to afford the desired DA cyclobutane (67) as seen in Scheme 4.4.

Scheme 4.4 Two-step synthesis of DA cyclobutanes

4.1.3 Cycloadditions of DA Cyclobutanes with cis-Diazenes

Because the Pagenkopf group was already performing cycloadditions with cis-diazenes for
DA cyclopropanes, I naturally progressed to trying the same diazene (PTAD) with DA
cyclobutanes. PTAD was selected as a desirable cis-diazene to work with because of its stability
and long shelf-life, and it can be easily synthesized using a straightforward synthetic route. A
common problem with other cis-diazenes is thermal instability leading to decomposition at room
temperature. Finding alternative cis-diazenes to undergo cycloaddition reactions with DA
cyclobutanes was made difficult due to their instability at room temperature and the limited
commercial availability of other cis-diazenes.
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Scheme 4.5 General cycloaddition of DA cyclobutanes with cis-diazenes
The general reaction is shown in scheme 4.5 and the parent molecule generated is a
hexahydropyridazine (73). Biological assays have shown hexahydropyridazines to exhibit
moderate levels of anesthetic, antihistaminic, and anticonvulsive activity.32 When PTAD is used
as the cis-diazene, a 5,6,5-ring system is generated through a formal [4+2] cycloaddition with DA
cyclobutane (67) as seen in Scheme 4.6. These products may potentially serve as a starting point
for the synthesis of other useful compounds, and also contain functionality to undergo postmodification.

Scheme 4.6 Cycloaddition of DA cyclobutanes with PTAD

4.2 Results and Discussion

After some experimentation, it was discovered that cis-diazenes such as PTAD are indeed
a compatible reaction partner for DA cyclobutanes. The [4+2] cycloaddition was achieved using a
necessary Lewis acid, and both GaCl3 and Yb(OTf)3 were successful. Optimization of the reaction
conditions led to GaCl3 being the better choice for a Lewis acid, with the highest yield occurring
at 5 mol % catalytic loading (Table 4.1).
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Table 4.1 Cycloaddition of DA cyclobutane with cis-diazene

Entrya

a

cis-Diazene
(Equivalents)
1

Lewis
Acid
Yb(OTf)3

Mol %

Yield (%)b

1

Cyclobutane
(Equivalents)
1

10

38

2

1

1

GaCl3

10

41

3

1.5

1

GaCl3

10

63

4

2

1

GaCl3

10

79

5c

2

1

GaCl3

5

92

6d

2

1

GaCl3

2

84

Typical reaction conditions: To a solution of GaCl3 in 1,2-DCE (3 mL) at room temperature,

was added cyclobutane (0.44 mmol) and nitrosoarene (0.22 mmol). Reactions were monitored
by TLC until cyclobutane was consumed.

b

Isolated yield.

c

20 min reaction time.

d

90 min

reaction time.

The cis stereochemistry of product (74c) was deduced from analyzing a crystal structure
as seen in Figure 4.1.

Figure 4.1 Crystal structure of hexahydropyridazine 74c
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4.2.1 Reaction Scope

After obtaining optimal reaction conditions for the cycloaddition, the scope was
investigated to see if other DA cyclobutanes were compatible with PTAD. Good yields were
obtained using various alkoxy-activated cyclobutane diesters as seen in Figure 4.2.

Figure 4.2 Cycloadditions of different DA cyclobutanes with PTAD

Reacting DA cyclobutanes with trans-diazenes was attempted but did not result in a
cycloaddition. This came as no surprise because of the difference in reactivity between transand cis-diazenes. The difference in reactivity was also observed when working with DA
cyclopropanes.
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4.3 Post Modification of Hexahydropyridazine Products

The methodology discovered enables easy access to the hexahydropyridazine ring system
through an efficient cycloaddition of DA cyclobutanes with cis-diazenes. Using specific DA
cyclobutanes, the diastereoselectivity can be controlled and can therefore be used in the
stereoselective synthesis of hexahydropyridazine systems. These systems contain the appropriate
functionality to undergo different post modification reactions (Scheme 4.7). This demonstrates the
versatility of the ring system to undergo various transformations to yield different compounds from
a single product. The post-modified products can then be potentially useful in the synthesis of
other target molecules or serve in other applications.

Scheme 4.7 Potential post modifications of hexahydropyridazine 74b
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4.4 Experimental
The procedures and conditions were the same as described in section 2.3.
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4.5 Supporting Information
General Procedure for Cycloaddition of cis-Diazene with DA Cyclobutane
To a solution of cyclobutane (0.43 mmol, 2.0 equiv) and PTAD (0.22 mmol, 1.0 equiv) in
1,2-DCE (3 mL) was added GaCl3 (0.01 mmol, 0.05 equiv) and stirred for 30 min at rt. The mixture
was then concentrated after consumption of cyclobutane (as indicated by TLC) and directly loaded
onto a packed SiO2 column. Product was purified by flash chromatography (1:1 hexanes/EtOAc)
to afford the corresponding cycloadducts.

Diethyl 8-ethoxy-1,3-dioxo-2-phenyltetrahydro-1H-[1,2,4]triazolo[1,2-a]pyridazine-5,5(6H)dicarboxylate (74a)
The general procedure for cycloaddition of cis-diazene with DA cyclobutane was followed using
cyclobutane (142 mg, 0.58 mmol), cis-diazene 49 (50 mg, 0.29 mmol) and GaCl3 (2.6 mg, 0.015
mmol) to yield the compound as a white solid. (109 mg, 90%). Rf 0.20 (3:1 Hexanes:EtOAc); 1H
NMR (600 MHz, CDCl3) 7.50 (app d, J = 8.2 Hz, 2 H), 7.45 (app t, J = 7.9 Hz, 2 H), 7.34 - 7.38
(m, 1 H), 5.54 (d, J = 1.8 Hz, 1 H), 4.25 - 4.37 (m, 4 H), 3.62 - 3.70 (m, 2 H), 2.69 (ddd, J = 14.1,
14.1, 4.1 Hz, 1 H), 2.47 - 2.51 (m, 1 H), 2.08 (d, J = 14.1 Hz, 1 H), 1.70 (dddd, J = 14.1, 4.1, 4.1,
4.1 Hz, 1 H), 1.27 - 1.33 (m, 6 H), 1.23 (t, J = 7.0 Hz, 3 H); 13C NMR (100 MHz, CDCl3) 166.2,
165.8, 153.7, 151.0, 131.0, 129.1, 128.3, 125.7, 77.6, 70.4, 65.0, 63.2, 63.0, 26.5, 25.6, 15.0, 14.1,
13.8; HRMS C20H25N3O7 Calculated = 419.1693, Found = 419.1699
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Diethyl 7,9-dioxo-8-phenylhexahydro-2H-furo[2,3-c][1,2,4]triazolo[1,2-a]pyridazine5,5(3H)-dicarboxylate (74b)
The general procedure for cycloaddition of cis-diazene with DA cyclobutane was followed using
cyclobutane (141 mg, 0.58 mmol), cis-diazene 49 (50 mg, 0.29 mmol) and GaCl3 (2.6 mg, 0.015
mmol) to yield the compound as a white solid. (111 mg, 92%). Rf 0.50 (1:1 Hexanes:EtOAc); 1H
NMR (400 MHz, CDCl3) 7.45 - 7.53 (m, 4 H), 7.38 (app t, J = 7.0 Hz, 1 H), 5.78 (d, J = 4.3 Hz, 1
H), 4.29 - 4.37 (m, 4 H), 4.18 - 4.23 (m, 2 H), 4.08 (td, J = 9.4, 2.0 Hz, 1 H), 2.64 (dd, J = 13.3,
5.9 Hz, 1 H), 2.40 - 2.48 (m, 1 H), 2.28 - 2.36 (m, 1 H), 2.24 (dd, J = 13.3, 12.1 Hz, 1 H), 1.90
(ddd, J = 6.6, 6.6, 2.0 Hz, 1 H), 1.34 (t, J = 7.0 Hz, 3 H), 1.32 (t, J = 7.0 Hz, 3 H); 13C NMR (100
MHz, CDCl3) 166.0, 165.6, 153.3, 150.5, 130.9, 129.2, 129.1, 128.4, 125.8, 80.8, 68.9, 66.2, 63.5,
63.1, 32.3, 31.7, 30.2, 14.1, 13.8; HRMS C20H23N3O7 Calculated = 417.1536, Found = 417.1530

Diethyl 8,10-dioxo-9-phenyloctahydropyrano[2,3-c][1,2,4]triazolo[1,2-a]pyridazine6,6(2H)-dicarboxylate (74c)
The general procedure for cycloaddition of cis-diazene with DA cyclobutane was followed using
cyclobutane (149 mg, 0.58 mmol), cis-diazene 49 (50 mg, 0.29 mmol) and GaCl3 (2.6 mg, 0.015
mmol) to yield the compound as a white solid. (97 mg, 78%). Rf 0.48 (1:1 Hexanes:EtOAc); 1H
NMR (400 MHz, CDCl3) 7.42 - 7.50 (m, 4 H), 7.36 (app t, J = 7.0 Hz, 1 H), 5.29 - 5.32 (m, 1 H),
4.26 - 4.38 (m, 4 H), 4.09 - 4.14 (m, 1 H), 3.65 (td, J = 12.1, 2.3 Hz, 1 H), 2.76 (dd, J = 13.1, 13.1
Hz, 1 H), 2.37 (dd, J = 13.1, 3.7 Hz, 1 H), 1.90 - 1.95 (m, 2 H), 1.81 - 1.88 (m, 2 H), 1.44 (d, J =
12.5 Hz, 1 H), 1.24 - 1.34 (m, 6 H);

13

C NMR (100 MHz, CDCl3) 166.3, 165.6, 152.6, 150.7,
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131.0, 129.1, 128.3, 125.8, 78.1, 69.6, 67.9, 63.4, 63.0, 30.0, 29.9, 27.1, 19.6, 14.1, 13.8; HRMS
C21H25N3O7 Calculated = 431.1693, Found = 431.1693

Diethyl 10a-methoxy-1,3-dioxo-2-phenyloctahydro-1H-[1,2,4]triazolo[1,2-a]cinnoline5,5(6H)-dicarboxylate (74d)
The general procedure for cycloaddition of cis-diazene with DA cyclobutane was followed using
cyclobutane (165 mg, 0.58 mmol), cis-diazene 49 (50 mg, 0.29 mmol) and GaCl3 (2.6 mg, 0.015
mmol) to yield the compound as a white solid. (99 mg, 75%). Rf 0.21 (3:1 Hexanes:EtOAc); 1H
NMR (400 MHz, CDCl3) 7.41 - 7.47 (m, 4 H), 7.31 - 7.35 (app tt, J = 7.0, 1.8 Hz, 1 H), 4.89 (dd,
J = 4.1 Hz, 1 H), 4.10 - 4.25 (m, 4 H), 3.85 (dd, J = 6.5, 4.1 Hz, 1 H), 3.45 (s, 3 H), 2.82 (dd, J =
15.3, 6.5 Hz, 1 H), 2.78 (dd, J = 15.3, 4.1 Hz, 1 H), 2.29 - 2.33 (m, 1 H), 2.10 - 2.19 (m, 2 H), 1.91
- 1.95 (m, 1 H), 1.66 - 1.70 (m, 2 H), 1.26 (t, J = 7.0 Hz, 3 H), 1.25 (t, J = 7.0 Hz, 3 H); 13C NMR
(100 MHz, CDCl3) 170.1, 169.2, 153.4, 152.2, 151.7, 129.0, 128.1, 125.7, 100.2, 64.7, 61.8, 61.5,
54.0, 48.4, 35.9, 31.9, 23.4, 19.0, 14.1; HRMS C23H29N3O7 Calculated = 459.2006, Found =
460.2090

Diethyl 11a-methoxy-1,3-dioxo-2-phenyldecahydrocyclohepta[c][1,2,4]triazolo[1,2a]pyridazine-5,5(1H)-dicarboxylate (74e)
The general procedure for cycloaddition of cis-diazene with DA cyclobutane was followed using
cyclobutane (173 mg, 0.58 mmol), cis-diazene 49 (50 mg, 0.29 mmol) and GaCl3 (2.6 mg, 0.015
mmol) to yield the compound as a white solid. (110 mg, 80%). Rf 0.53 (1:1 Hexanes:EtOAc); 1H
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NMR (400 MHz, CDCl3) 7.48 - 7.50 (m, 2 H), 7.45 (app t, J = 7.9 Hz, 2 H), 7.34 (app t, J = 7.6
Hz, 1 H), 4.58 (app dd, J = 4.5, 2.3 Hz, 1 H), 4.19 - 4.23 (m, 4 H), 3.47 - 3.53 (m, 1 H), 3.34 (s, 3
H), 3.27 (s, 3 H), 2.32 - 2.38 (m, 1 H), 2.03 - 2.08 (m, 1 H), 1.91 - 1.95 (m, 2 H), 1.78 - 1.80 (m,
2 H), 1.53 - 1.65 (m, 5 H), 1.24 - 1.27 (m, 6 H); 13C NMR (100 MHz, CDCl3) 169.6, 169.4, 153.3,
129.1, 128.1, 125.4, 105.0, 62.3, 61.5, 61.0, 51.3, 50.3, 48.6, 41.0, 30.3, 27.5, 25.2, 24.6, 24.5,
21.1, 14.1; HRMS C24H31N3O7 Calculated = 473.2162, Found = 473.2165

Diethyl 8-(4-methoxyphenyl)-1,3-dioxo-2-phenyltetrahydro-1H-[1,2,4]triazolo[1,2a]pyridazine-5,5(6H)-dicarboxylate (74f)
The general procedure for cycloaddition of cis-diazene with DA cyclobutane was followed using
cyclobutane (48 mg, 0.16 mmol), cis-diazene 49 (14 mg, 0.08 mmol) and GaCl3 (0.7 mg, 0.004
mmol) to yield the compound as a white solid. (34 mg, 88%). Rf 0.45 (1:1 Hexanes:EtOAc); 1H
NMR (400 MHz, CDCl3) 7.39 - 7.47 (m, 5 H), 7.34 (app d, J = 8.6 Hz, 2 H), 6.86 (app d, J = 8.6
Hz, 2 H), 5.11 (dd, J = 11.3, 4.3 Hz, 1 H), 4.20 - 4.31 (m, 4 H), 3.79 (s, 3 H), 3.49 (dd, J = 8.4, 4.5
Hz, 1 H), 2.09 - 2.23 (m, 2 H), 1.80 - 2.04 (m, 2 H), 1.29 (t, J = 7.0 Hz, 6 H); 13C NMR (100 MHz,
CDCl3) 169.7, 169.4, 154.1, 129.0, 128.9, 128.1, 125.5, 114.1, 61.9, 59.7, 55.3, 50.7, 29.0, 26.6,
25.0, 14.1; HRMS C25H27N3O7 Calculated = 481.1849, Found = 481.1837
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Chapter 5 - Conclusions

This thesis has investigated the mechanism of reaction between DA cyclopropanes and
nitrosoarenes. The reaction of DA cyclopropanes with azo dicarboxylates was also investigated.
These reactions were studied with the use of cross-over experiments. The information learned from
these experiments could be used in the development of new reactions. The successful completion
of these projects demonstrates the usefulness and versatility of DA cyclopropanes in synthetic
organic chemistry.
A breakthrough that was discovered in this thesis included the general pattern of reactivity
of nitrogen to open a DA cyclopropane, which undergoes fragmentation and generation of a 1,3dipole. This reaction type may lead to the discovery of new reactions if further exploration is
attempted. This reaction represents a novel way of synthesizing heterocyclic compounds and
incorporating new atoms may allow for construction of new heterocycles.
The reaction of DA cyclobutanes with cis-diazenes was also accomplished in a highly
efficient cycloaddition. The generality of the reaction scope was achieved from the successful
coupling of different DA cyclobutanes with cis-diazene, PTAD. This project showcased a novel
approach to the synthesis of hexahydropyridazine systems. These six-membered ring heterocycles
have limited ways to be created, and can now be efficiently synthetized, which demonstrates the
usefulness of this chemistry.
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